PARACELLULAR EPITHELIAL TRANSPORT MAXIMIZES ENERGY EFFICIENCY IN THE KIDNEY by Pei, Lei
 





Submitted to the graduate degree program in Molecular and Integrative Physiology and the 
Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the 
degree of Doctor of Philosophy 
 
________________________________        
    Alan S. L. Yu, M.B., B.Chir, Chair           
 
________________________________        
Gustavo Blanco, M.D, Ph.D 
________________________________        
Bruno Hagenbuch, Ph.D 
________________________________        
Reena Rao, Ph.D 
________________________________        
Darren Wallace, Ph.D 
 
 



















PARACELLULAR EPITHELIAL TRANSPORT MAXIMIZES ENERGY EFFICIENCY IN THE 
KIDNEY 










                                                                                    ____________________________ 
   
    Alan S. L. Yu, M.B., B.Chir, Chair          
 





         Claudins are tight junction transmembrane proteins that act as paracellular ion channels. 
The proximal renal tubule reabsorbs 70% of glomerulus-filtered Na+. Of this Na+, up to 1/3 is 
reabsorbed passively via the paracellular pathway. Claudin-2 has been shown to mediate 
paracellular sodium reabsorption in the proximal tubule of the kidney. Claudin-2 null mice are 
reported to have markedly decreased proximal tubule Na+, Cl- and fluid reabsorption, but they 
have no apparent disturbance in overall Na+ balance.  
          We investigated whether we can uncover the salt-wasting phenotype of claudin-2 knockout 
mice by challenging them with Na+ depletion. Even during profound dietary sodium depletion, 
claudin-2 null mice demonstrated the ability to conserve sodium to the same extent as wild-type 
mice. We investigated how the Na+ wasted from the proximal tubule was compensated in other 
segments of the renal tubule. We performed immunoblot on transcellular Na+ transporters Na-H 
antiporter 3, Na-K-2Cl cotransporter, NaCl cotransporter and epithelial Na+ channel. We found no 
upregulation of the protein abundance of any of these transcellular transporters.  To test whether 
there was functional upregulation of transcellular Na+ transport distally, diuretic challenge tests 
were performed. The natriuresis 4 hours after intraperitoneal furosemide (but not after 
hydrochlorothiazide or benzamil) was 40% higher in claudin-2 null mice than in WT mice, 
indicating that the site of compensation was the thick ascending limb. We concluded that claudin-
2 null mice are able to conserve sodium to the same extent as wild-type mice, even under extreme 
conditions, due to upregulation of transcellular Na-K-2Cl transport activity in the thick ascending 
limb of Henle.  
          We therefore hypothesized that the shifting of sodium transport to transcellular pathways 
would lead to increased whole kidney oxygen consumption. Indeed we found that the kidneys of 
claudin-2 null mice have markedly increased oxygen consumption despite normal sodium 
reabsorption, and consequently have medullary hypoxia. Furthermore, when subjected to bilateral 
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renal ischemia-reperfusion injury, kidneys of claudin-2 null mice exhibited more severe tubular 
injury.    
         In summary, our findings suggest a more important reason for the existence of the 
paracellular transport pathway, namely that it evolved to enhance the efficiency of energy and 
oxygen utilization by the renal tubule epithelium. Our research demonstrates that claudin-2 is a 
key paracellular pathway for passive Na+ absorption in the proximal tubule that reduces the overall 
energy expenditure by the kidneys. This dissertation sheds light on a fundamental metabolic 
process and thereby provides insight on the process that may have broader significance for 
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1.1 Claudins mediate epithelial paracellular transport 
1.1.1 Paracellular transport through tight junctions between epithelial cells 
        Epithelia are sheets of cells that separate body compartments of different compositions and 
function as physical and chemical barriers. Epithelia have two functions: 1) to protect the tissues 
underneath from physical trauma, toxins and invasion by pathogens; and 2) to absorb nutrients 
and excrete waste by transporting molecules through the epithelia (Lommel 2003). 
        For almost a century, it was believed that epithelial cells were attached to each other by an 
impermeable seal that was referred to as the "terminal bar." The understanding of how ions 
selectively cross epithelia originates with Hans Ussing’s work. Ussing addressed the question of 
how sodium ions were moved in a directional fashion across the epithelium of frog skin, resulting 
in a steady-state electrical potential across the epithelium (Ussing and Zerahn 1951, Koefoed-
Johnsen and Ussing 1958). As a first conceptual breakthrough, the "two membrane model" was 
first used to explain transepithelial transport. This model demonstrated that the apical and basal 
membrane surfaces had different conductance properties, namely, that Na+ enters the cell across 
the apical membrane down its concentration gradient (later shown to occur through Na+ channels) 
but was transported in an energy-dependent fashion out the basolateral surface (later shown to 
occur via the Na+-K+-ATPase). When transcellular transport was inhibited, they observed that 
there was still directional transport of ions through the epithelium. This led to the conclusion that 
Cl- ions must be following Na+ in a passive fashion through the tight junction coupled to the 
electrical gradient generated by active Na+ transport (Ussing & Windhager, 1964). This was the 
beginning of the understanding of how transcellular and paracellular transport are physiologically 
coupled (Fig.1.1). 
 
1.1.2. Claudins in tight junctions regulate paracellular permeability 
         After measuring permeability and permselectivity of various epithelia from different organs 
(Crone and Christensen 1981, Powell 1981), it turned out that transepithelial resistance differs by 
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several orders of magnitude between “tight” and “leaky” epithelia. For example, the transepithelial 
resistance of the epithelium of the toad urinary bladder is 300,000 Ω•cm2 compared with the 
mammalian proximal tubule with only about 6 Ω•cm2 (Powell 1981, Van Itallie, Rogan et al. 2006). 
The leakiness of the epithelia is believed to be determined by the tight junctions which are 
believed to have ionic charge selectivity. The introduction of electron microscopy in the 1950s led 
to the description of the intercellular junctional complex and the tight junctions (Farquhar and 
Palade 1963). Shortly thereafter it became apparent (particularly in leaky epithelia) that the so-
called "tight" junctions actually constitute a paracellular pathway that exhibits passive permeability 
to small ions (Whittembury and Rawlins 1971).  
        Tight junctions form the continuous intercellular barrier between epithelial cells, which is 
required to separate tissue spaces and regulate selective movement of solutes across the 
epithelium. The tight junction has a surprisingly complex protein composition compared to other 
cell junctions and is composed of more than 40 proteins. These proteins that constitute the multi-
molecular tight junction complex can be divided into three groups: 1) integral tight junction 
proteins that bridge the apical intercellular space and form a regulated permeability barrier; 2) 
tight junction plaque proteins that serve as links between the integral tight junction proteins and 
the actin cytoskeleton and as adapters for the recruitment of cytosolic molecules that are involved 
in cell signaling; 3) a variety of cytosolic and nuclear proteins, including regulatory proteins, tumor 
suppressors, and transcriptional and posttranscriptional factors that interact either directly or 
indirectly with tight junction plaque proteins to coordinate various functions such as the regulation 
of paracellular solute permeability, cell proliferation, cell polarity, and tumor suppression 
(Schneeberger and Lynch 2004). Among these proteins, the claudin family is reportedly critical in 
regulating paracellular permeability by influencing pore size, electrical resistance, and ion 
permeability preference. Claudins are encoded by a family of 28 genes in mammals (Mineta, 
Yamamoto et al. 2011). They range from 20 to 27 kDa and have four transmembrane helices: a 
short internal amino-terminal sequence (2–6 residues), two extracellular domains (loop 1 is 49–
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52 residues and loop 2 is 16–33 residues), and a longer and more variable cytoplasmic tail (21–
63 residues) (Suzuki, Nishizawa et al. 2014). Permeability and selectivity are influenced by the 
number and position of charged amino acid residues on the first extracellular loop of claudins 
(Colegio, Van Itallie et al. 2002). Amino acid mutations on the first extracellular loop lead to 
changes in both transepithelial electrical resistance (Uhlen, Oksvold et al. 2010) and charge 
selectivity (Colegio, Van Itallie et al. 2002).  
        Knocking out claudins in mice can induce either barrier function or pore function defects. 
Knocking out claudin-1 (Ladwein, Pape et al. 2005), claudin-5 (Nitta, Hata et al. 2003) or claudin-
15 (Tamura, Kitano et al. 2008) caused defects in barrier function of the tight junctions. However, 
deleting claudin-16 (Himmerkus, Shan et al. 2008) and claudin-19 (Hou, Renigunta et al. 2008) 
genes led to impaired ion permeability of the renal tubule epithelium. 
       The majority of claudin family members are expressed in the kidney, and most are localized 
to renal epithelial cells (Kiuchi-Saishin, Gotoh et al. 2002). The locations of each claudin isoform 
are diverse. Figure 1.2 illustrates the distribution of several claudins in a nephron. Claudin-2 is 
expressed in the proximal tubule and the early thin descending limb (Enck, Berger et al. 2001).  
 
1.2 Renal Proximal Tubules affect the metabolic balance of the human body 
1.2.1 Physiological role of renal proximal tubule 
        Proximal tubules reabsorb all glomerulus-filtered glucose, amino acids and about 60% of 
Na+, K+, and Cl-. Proximal tubules are important because various serious inherited or acquired 
kidney disorders such as Fanconi disease, renal tubular acidosis, and phosphate wasting 
syndromes are associated with the disruption of the function of transporters in proximal tubule 
cells (Nakhoul and Batuman 2011). Approximately 3% to 7% of hospitalized patients and 25% to 
30% of ICU patients develop acute kidney injury. Although all the nephron segments may be 
injured during acute kidney injury, the most common renal segment susceptible to acute kidney 
injury from ischemia, sepsis, or other nephrotoxins is the proximal tubule, especially the S3 
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segment of the proximal tubule located in the outer stripe of the medulla. Understanding the exact 
mechanism of solute and water transport in proximal tubules can assist in the development of 
appropriate therapeutics for these inherited and acquired renal diseases. 
 
1.2.2 Paracellular transport is important in handling Na+, Cl-, and water in renal proximal 
tubules. 
        In early proximal tubules, Na+ is reabsorbed transcellularly with HCO3- (Kokko 1973), and 
isosmotic water reabsorption follows. These phenomena generate a lumen-negative electrical 
potential across the tubule. Meanwhile, the lumen-to-plasma concentration gradient in late 
proximal tubules is high in Cl- and low in HCO3- as fluid flows down to the later proximal tubule 
(Bomsztyk 1986). Paracellular tight junctions in the early proximal tubules are permeable to Cl-. 
This negative lumen potential drives paracellular Cl- reabsorption (Andreoli, Schafer et al. 1979). 
Enhanced Cl- reabsorption generates a slightly lumen-positive transepithelial potential in mid to 
late proximal tubules. Thus, Na+ is reabsorbed in mid-to-late proximal tubules, driven by the 
positive electrical gradient (Barratt, Rector et al. 1974) (Fig. 1.3). 
 
1.2.3 The paracellular permeability of proximal tubules is believed to be determined by 
claudins in tight junctions 
        Tight junctions form intercellular barriers that selectively regulate solute movement. Among 
the various protein components that were discovered in tight junctions, the claudin family plays a 
key role in regulating paracellular permeability. Permeability and selectivity are influenced by the 
number and position of charged amino acid residues on the first extracellular loop of claudins 
(Colegio, Van Itallie et al. 2002, Yamazaki, Okawa et al. 2008).  
        The claudin isoforms are expressed in various organs in the body, such as the kidneys, the 
intestines and brain ventricles. The majority of the claudin family members are expressed in the 
kidney, and most are localized to the renal epithelial cells (Kiuchi-Saishin, Gotoh et al. 2002). 
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Claudin isoforms have diverse locations. Figure 1.2 illustrates the distribution of several claudins 
in a nephron. The pattern of claudin expression in different segments of the renal tubule is 
important for the particular ion permeability of each tubular segment. For example, in vitro studies 
show that claudin-7, which is expressed in the distal convoluted tubule and the collecting duct, 
mediates Cl- permeability (Tatum, Zhang et al. 2007).Claudin-7 knockout mice exhibited renal salt 
wasting and chronic dehydration (Tatum, Zhang et al. 2010). Claudin-16 and claudin-19 
expressed in the thin and thick ascending limb were found to work synergistically to mediate 
cation permeability (Konrad, Schaller et al. 2006, Angelow, El-Husseini et al. 2007, Hou, 
Renigunta et al. 2008). It was observed that mutations of claudin-16 and/or claudin-19 in both 
human and mice resulted in Mg2+ and Ca2+ wasting (Weber, Schneider et al. 2001, Himmerkus, 
Shan et al. 2008). 
 
1.3 Investigation of the functional role of claudin-2 
1.3.1 Characterization of the function of claudin-2 in vitro 
        The hallmark discovery of claudin-2 function occurred when researchers found that the 
transepithelial resistance of Madin–Darby canine kidney type I (MDCKI) cells, a high-resistance 
cell line, when transfected with claudin-2, dropped to the level of Madin–Darby canine kidney type 
II (MDCKII) cells, a leaky cell line that shares the same components with the MDCKI cell line, 
except that MDCKII endogenously expresses claudin-2 (Furuse, Furuse et al. 2001). Later studies 
showed that the transfection of claudin-2 into high-resistance Madin–Darby canine kidney type 
C7 (MDCK-C7) cells induces paracellular channels with a permeability preference for cations 
such as K+ and Na+ over anions such as Cl- and Br-(Amasheh, Meiri et al. 2002); these results 
indicate that claudin-2 forms leaky and cation-selective pores. 
 
1.3.2 Characterization of the function of claudin-2 in vivo 
        The first claudin-2 null mice were characterized by Muto et al (Muto, Hata et al. 2010). In 
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isolated perfused proximal tubule S2 segments from these mice, there was a 2.5-fold increase in 
transepithelial resistance, a decrease in Na+/Cl- permeability ratio (pNa/pCl), and a 37% decrease 
in net Na+ reabsorption, demonstrating that claudin-2 plays a major role in paracellular Na+ 
transport in the proximal tubule (Muto, Hata et al. 2010). Schnermann et al subsequently 
confirmed that these mice have a 23% reduction in proximal fluid reabsorption (Schnermann, 
Huang et al. 2013). Although it was predicted that these mice would exhibit urinary NaCl wasting, 
this was not observed in metabolic balance studies on a normal diet, raising the question of what 
role, if any, claudin-2 plays in normal physiology.  
 
1.4 Paracellular transport saves energy 
        Why is paracellular transport necessary for renal transepithelial transport? Can transcellular 
transport by itself accommodate all solutes and water? These questions led us to consider one 
key difference between paracellular transport and transcellular transport: the consumption of 
energy. All transcellular transport processes in nephrons are driven by the potential energy 
generated by the Na-K-ATPase on the basolateral membrane of renal tubule cells. Each cycle of 
the pump hydrolyzes 1 ATP molecule while transporting 3Na+ out of the cell and 2K+ into the cell. 
Therefore, consumption of 1 ATP molecule can transport 3Na+ from the lumen to the blood 
(Horisberger 2004, Skou 2004). In the 1960s, researchers measured the energy cost of tubular 
reabsorption in mammals, and the kidney was calculated to reabsorb 25Na+ to 29Na+ per O2 
molecule consumed(Kiil, Aukland et al. 1961, Torelli, Milla et al. 1966) If we assume that the 
mitochondria generate 6 ATP molecules from 1 O2 molecule, the kidney must therefore reabsorb 
4 Na+ to 5 Na+ per ATP molecule, which is more than 3 Na+ per 1 ATP molecule that we predicted. 
One possible reason for the lower-than-expected energy consumption of Na+ transport is the 
existence of paracellular transport. A portion of the solute is believed to be transported driven by 
electrical and chemical gradients created by transcellular transport. The ratio of O2 consumed per 
Na+ reabsorbed reportedly increases during carbonic anhydrase inhibition (Mathisen, Monclair et 
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al. 1980, Weinstein, Klose et al. 1984). These findings suggest that when HCO3- reabsorption was 
inhibited in the proximal tubule, water was also not reabsorbed. Thus, the concentration gradient 
for Cl- could not be generated in the early proximal tubule, and this led to impaired paracellular Cl- 
and Na+ reabsorption. As a result, more Na+ was reabsorbed through the transcellular pathway 
and in turn more O2 was consumed.  
         Based on this hypothesis, depletion of paracellular transport in the kidney may increase the 
workload of transcellular transporters. The kidney would consume more energy and consequently 
more O2 than normal kidneys. To the best of our knowledge, evidence is lacking on the effect of 
the direct inhibition of paracellular transport in the proximal tubule on oxygen consumption 
efficiency. This idea has not been tested yet in vivo. Moreover, no study has reported on the 
extent of effect on total kidney O2 consumption if the paracellular pathway in the proximal tubule 
is knocked out and whether it has any physiological significance. Thus, we will explore these 
issues by studying claudin-2 KO mice. The ability to ablate paracellular Na+ transport in the 
proximal tubule by gene targeting of claudin-2 in mice afforded us a unique opportunity to test this 
directly. 
 
1.5 Significance and purpose of this dissertation 
        Researchers have found a variety of in vitro evidence showing that claudins play a critical 
role in reabsorption of ions (Coyne, Gambling et al. 2003, Alexandre, Lu et al. 2005, Hou, 
Renigunta et al. 2008, Amasheh, Milatz et al. 2009, Borovac, Barker et al. 2012, Krug, Gunzel et 
al. 2012). However, the in vivo characterization is not thoroughly-studied, especially for the 
claudins that mediate Na+ or Cl- reabsorption, such as claudin-2, claudin-7 and claudin-10a. The 
salt wasting phenotypes of these claudin knockout mice are usually absent or mild (Muto, Hata et 
al. 2010, Tatum, Zhang et al. 2010). One important factor that needs to be taken into consideration 
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is that there are so many Na+ transporters along the renal tubule. Some examples are: Na-H 
antiporter 3 (NHE3) in the proximal tubules, Na-K-2Cl cotransporter (NKCC2) in the thick 
ascending limb, NaCl cotransporter in the distal convoluted tubules, and epithelial Na+ channel 
(ENaC) in the cortical collecting duct. Na+/K+-ATPase, which is present in the basolateral 
membrane, creates a concentration gradient for sodium to flow into the cell through apical 
transporters. As apical transporter activity increases, so too does Na+/K+-ATPase activity in order 
to maintain the low intracellular Na+ environment. These transporters play a significant role in the 
regulation of Na+ reabsorption in renal tubules. It has been shown that when one transporter is 
dysfunctional, other transporters will compensate for it (Brooks, Sorensen et al. 2001). Whether 
there is any compensation by other Na+ transporters in claudin-null mice has never been 
investigated. In this dissertation, we performed a series of experiments to uncover the mystery 
behind the absence of the salt-wasting phenotype in claudin-2 null mice. We studied whether 
other Na+ transporters could compensate and prevent the salt wasting phenotype in claudin-2 null 
mice. In addition we further investigated the fundamental significance of paracellular transport. 
We are the first to prove that paracellular transport evolved to make ion transport more energy-
efficient. It utilizes the gradient that was created by transcellular transport and mediates ion 
transport without directly consuming oxygen. Without paracellular transport, the tissue will be 







Figure 1.1 Electrical circuit model of paracellular resistances across transcellular and paracellular 
pathways of an epithelial cell monolayer. Transcellular transport is controlled by transporters in 
the apical and basolateral surfaces. The resistance of these series elements is typically much 
higher than that of the parallel elements of the paracellular pathway. Thus, the overall resistance 
of an epithelium is defined by RTJ, which is defined by the composition of claudins in the tight 
junctions (Anderson and Van Itallie 2009). RTJ: resistance of tight junction; RBL: basolateral cell 





Reprint with permission of Cold Spring Harbor Laboratory Press. All rights reserved. Cold Spring 







Figure 1.2 Distribution and putative function of claudin proteins in mouse nephron segments. 
Summary of the segment-specific expression patterns of claudins in mouse nephrons. In the thin 
descending limb of Henle, some, but not all, aquaporin 1-positive tubules were positive for 
claudin-2 (CLDN-2). Similarly, from the thin ascending limb of Henle to the collecting duct, claudin-
3 was detected in some, but not all, marker-positive tubules. These findings may be consistent 
with previous reports that the distal tubules, as well as the collecting tubules, are composed of 
several functionally distinct segments. In other cases, claudins were detected in all of the 
respective marker-positive tubules (Angelow, Ahlstrom et al. 2008). 
 
Reprint with permission of American Physiological Society and American Journal of Renal 




Figure 1.3 Transepithelial Na+–Cl- transport in the proximal tubule. In early renal proximal tubules, 
Na+ is actively transported into proximal tubule cells by the Na+–H+ antiporter and then exits the 
basolateral membrane through the Na+–HCO3- cotransporter. This phenomenon leads to 
increased Cl- gradient and thus drives paracellular Cl- reabsorption through claudin-10a pores. 
The Cl- reabsorption generates a positive lumen potential and drives paracellular Na+ and K+ 































        After we purchased claudin-2 null mice, we bred them with C57BL/6J mice to generate 
different genotypes. We then performed a Southern blot to confirm the absence of the claudin-2 
gene in the knockout mouse genome. Also, we used RT-PCR, western blot and 
immunofluorescence to confirm the absence of claudin-2 mRNA and protein expression. We 
characterized the claudin-2 expression and localization in heterozygous mice to see whether 
there was any lyonization. Muto et al reported that although isolated claudin-2 null proximal 
tubules revealed less permeability to Na+, there was no change in urinary Na+ excretion unless 
they challenged the mice with a high salt saline infusion (Muto, Hata et al. 2010). We performed 
a similar experiment to confirm this result.  
 
2.2 Methods and Materials  
Animal source and breeding scheme 
         Mice - in which the single coding exon of claudin-2 on the X chromosome was replaced by 
a βGeo/Puro cassette by homologous recombination (Fig. 2.1) and maintained on a B6;129F2 
segregating background (B6;129S5-Cldn2tm1Lex/Mmcd) - were purchased from Mutant Mouse 
Regional Resource Centers. These chimeric mice were bred with C57BL/6J mice to generate F1 
heterozygous animals. Their progeny were then intercrossed to generate F2 heterozygous mice 
Cldn2 [+/-]. Given that the resulting F2 Cldn2 [+/-] mice have a mixed background, we bred the 
Cldn2 [+/-] mice with Cldn2[+/Y] mice containing a pure C57BL/6 background in order to generate 
hemizygous Cldn2[-/Y] and WT [+/Y]. Then we bred claudin-2 heterozygous mice Cldn2 [+/-] with 
claudin-2 hemizygous mice Cldn2[-/Y] to generate claudin-2 homozygous mice Cldn2[-/-]. Figure 
2.2 shows the schematic of our breeding strategy that produced the generation of hemizygous 





         Genomic DNA from claudin-2 WT and KO kidney was extracted using phenol and 
chloroform and purified with 70% ethanol. The extracted genomic DNA was digested with EcoR1 
at 37° overnight. We separated the digested DNA samples in a 0.5X Tris/Borate/EDTA (TBE) gel 
at 20 volts for 8 hours in 1X TBE buffer. The targeted DNA was transferred to a nitrocellulose 
membrane (Boehringer-Mannheim cat#:1417240) via electrophoretic transfer (Genie Blotter), 
denatured by NaOH and fixed by UV crosslinker. A 3’ external probe and a 5’ external probe were 
labeled with [α32P] dCTP using the High Prime DNA labeling kit (Roche 11585584001). The 
membrane was hybridized with α32P labeled DNA probe at 42°C overnight. We washed the 
membrane with 2X SSC/ 0.1% SDS for 15 minutes at room temperature twice, and then switched 
the washing buffer to 0.5X SSC/ 0.1% SDS for 15 minutes at 65°C once. The radioactive signal 
from the membrane was absorbed for 24 hours by a storage phosphor screen and then scanned 
by a typhoon scanner. A 5’ external probe was produced via PCR of mice genomic DNA using 
the primers:  
Forward: 5’-GAGTACTGTGTAAGGTACAYG-3’ 
Reverse: 5’-CATAGTGCTAAGAATGCAG-3’ 







         The preparation of the whole kidney lysates was described in previous studies (Nguyen, 
Yang et al. 2012). Briefly, one whole kidney of each mouse was minced and suspended in 2 ml  
isolation buffer (5% sorbitol, 0.5 mM disodium EDTA, and 5 mM histidine-imidazole buffer, pH = 
7.5, with the addition of 167 mM PMSF, 9 μg/ml aprotinin, and 5 μl/ml phosphatase inhibitor 
cocktail [Sigma]). Each sample was homogenized for 5 min at a low-speed setting with an Ultra-
Turrax T25 (IKA-Labortechnik) and then centrifuged at 2,000 g for 10 min. Supernatants were 
retained, and the pellets were rehomogenized in another 2 ml of isolation buffer, recentrifuged, 
and the resulting supernatants were pooled with the first supernatants. 
           Equal amounts of the supernatant proteins from the kidney lysates were boiled at 60 C̊ for 
20 minutes and loaded to 10% acrylamide gels (Bio-Rad) for electrophoresis. After that, the 
proteins were transferred to polyvinyl di-fluoride (PVDF) membranes. Non-specific binding was 
blocked by gently agitating the membranes in 5% non-fat milk and 0.1% Tween in PBS (PBST) 
for 1 hour at room temperature. Blots were subsequently incubated in 5% bovine serum albumin 
(BSA) containing 0.1% Tween with the designated primary antibody (Table 2.1) overnight at 4°C 
with gentle agitation. After PBST washes, the blot was then incubated with the appropriate 
horseradish peroxidase-conjugated secondary antibody for 1 hour at room temperature with 
gentle agitation. After PBST washes, the blots were incubated with Pierce™ ECL Western Blotting 
Substrate (Thermoscientific). 
          Equal loading of WT and KO kidney protein lysates represented the same percentage of a 
whole kidney since there was no difference in kidney weight between WT and KO mice (Fig. 2.3). 
The immunoblot signals were quantitated with the Odyssey Infrared Imaging System (Li-COR). 






          In a separate set of WT and claudin-2 KO mice, kidneys were perfusion-fixed via the heart 
with 4% paraformaldehyde in PBS. The fixed tissues were cryoprotected by overnight incubation 
with 30% sucrose in 1X Phosphate-buffered saline (PBS), embedded in Tissue-Tek O.C.T. 
compound (Sakura Finetek, Torrance, CA), and frozen on dry ice. Cryosections (10 μm) from WT 
and KO animals were sliced and transferred to the same Superfrost Plus-charged glass slide 
(Fisher) for direct side-by-side processing and viewing. For immunofluorescent labeling, the 
sections were rehydrated and antigen-retrieved via immersing the slides in 1X antigen decloaker 
solution and steaming the slides in a pressure cooker for 5 minutes. After that, the slides were 
washed and blocked with 1% BSA/5% goat serum/PBS for 1 hour at room temperature before 
antibody incubation. All antibodies (see Table 2.2) were diluted in 1% BSA/5% goat serum/PBS. 
The blocked kidney sections were incubated with primary and secondary antibodies at room 
temperature for 1 hour each. Between each incubation, the sections were washed with 1XPBS 5 
minutes for 3 times. After that, the sections were mounted in Prolong Anti-fade containing DAPI 
(Invitrogen) and air dried overnight. 
 
RNA extraction and quantitative real-time PCR 
         RNA was extracted from tissue homogenate with TRI Reagent (Sigma-Aldrich) and purified 
using an RNeasy mini kit (Qiagen).  First-strand cDNA was synthesized using iScript Reverse 
Transcription Supermix for RT-PCR (Bio-rad). Quantitative real-time PCR was performed using a 
CFX96 Touch™ Real-Time PCR Detection System and iTaq™ Universal SYBR® Green 
Supermix (Bio-rad) with the primers indicated in Table 2.3. Expression levels were normalized to 
β-actin levels. 
Blood and urine studies 
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         Mouse whole blood was collected through cardiac puncture. The blood was left undisturbed 
at room temperature for 30 minutes to allow it to clot and the clot was removed by centrifuging at 
1,000 x g for 10 minutes in a refrigerated centrifuge. Serum potassium was measured via flame 
photometer (BWB Technologies). Na+ concentration was measured with a sodium ion-sensitive 
microelectrode and urine volume was measured by urine weight. 
 
NaCl hypertonic saline challenge experiment 
        Mice were given 40 mL/kg bodyweight of a 2% (weight/volume) sterile NaCl solution via 
intraperitoneal injection. After the injection, the mice were housed in metabolic cages individually 
for 4 hours to collect urine. Urine Na+ excretion was calculated as “urine Na+ concentration X urine 
volume.” Na+ concentration was measured with a Na+ ion-sensitive microelectrode and urine 
volume was measured by urine weight. 
 
Low potassium diet metabolic study 
          Mice were placed in metabolic cages for 10 days and fed custom purified rodent diets 
(Teklad, Harlan Laboratories). A control diet containing 0.8% potassium (TD.120258) was 
provided for the first 5 days and then switched to a potassium-deficient diet containing 0.006% 
potassium (TD.120260) for the next 5 days. Urine was collected daily except on the first day after 
the switch to the potassium-deficient diet, when urine was collected every 8 hours. This was done 





         All animal experiments were performed in accordance with NIH guidelines on the use of 
laboratory animals as well as by the Institutional Animal Care and Use Committee at the University 
of Kansas Medical Center. 
 
Data analysis 
         Data are expressed as means ± standard error of the means (SEM). To compare means 




          In order to produce claudin-2 null mice with a pure C57BL/6J background, first generation 
claudin-2 heterozygous mice were bred to C57BL/6J mice for more than 10 generations. Their 
growth rate, appearance, activity and behavior were normal. Because the claudin-2 gene is on 
the X chromosome, we used male hemizygous mice Cldn2[-/Y] as the KO mice and compared 
them to their male wild-type littermates Cldn2[+/Y] for matched controls (WT). Southern blot 
confirmed the disruption of the claudin-2 gene in claudin-2 KO mice (Fig. 2.4). Quantitative RT-
PCR and Western blotting confirmed the absence of claudin-2 in hemizygous KO Cldn2[-/Y] mice 
(Fig. 2.5 A and B). There was an intermediate level of expression of claudin-2 in heterozygous 
female Cldn2[+/-] mice.  Immunofluorescence confirmed that claudin-2 was expressed and 
localized in tight junctions in WT mouse kidney proximal tubules in a continuous distribution but 
were absent from the KO kidneys. Heterozygous kidneys showed a discontinuous distribution of 
claudin-2 in only some of the proximal tubule cells, presumably due to lyonization (Fig. 2.5C).  
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          The intraperitoneal injection of mice with a hypertonic (2%) saline solution resulted in a 
higher urine Na+ excretion in claudin-2 KO mice (Fig. 2.6). To investigate whether other 
paracellular transport pathways were upregulated to compensate for the lack of claudin-2, we 
performed quantitative real-time PCR for other claudins expressed in the proximal tubule (claudin-
10a, -17), the thick ascending limb (claudin-10b, -16 and -19) and the distal tubule (claudin-4, -8). 
We found no difference in the expression (Figure 2.7 and 2.8B) or localization (Fig. 2.8A) of any 
of these claudins between KO and WT mice. To investigate whether claudin-2 depletion has any 
influence on renal potassium handling, we performed a 10-day metabolic study to measure serum 
K+ levels at the baseline and during a low potassium diet. No difference was detected in serum 
K+ levels between the claudin-2 WT and KO mice (Fig. 2.9). Age-matched adult (8 weeks old) 
claudin-2 WT and KO mice were placed in metabolic cages and were fed a control diet with normal 
sodium content (0.3% sodium, 0.8% potassium) for 5 days. Urine collected daily showed no 
significant difference in the urine potassium/creatinine (K/Cr) concentration ratio between the WT 
and KO mice (Fig. 2.10). After the 5-day acclimatization period, the mice were switched to a 
matched potassium-deficient diet (0.006% potassium) and urine K+ was monitored 8 hourly for 
the first 24 hours, and daily thereafter. Any inability of the KO mice to maximally conserve K+ 
would have manifested itself as a transiently higher K+ excretion rate as compared to WT mice, 
in which K+ excretion rate returns to a steady-state within a few days. We did not find any 
difference in urine K+ excretion rates between WT and KO mice. 
 
2.4 Discussion 
         Claudin-2 null mice were born with expected Mendelian ratios. There was no overt 
phenotype of claudin-2 null mice at the baseline; they grew and bred normally. This observation 
was consistent with what has been previously reported (Muto, Hata et al. 2010). We confirmed 
that the claudin-2 gene was disrupted in the claudin-2 null mice genome. We also confirmed the 
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absence of claudin-2 mRNA and protein expression in KO and intermediate claudin-2 expression 
in heterozygous mice. Claudin-2 is also known to mediate K+ permeability in vitro (Amasheh, Meiri 
et al. 2002). Around 60% of the K+ is believed to be transported via claudin-2 between proximal 
tubule cells. Therefore we expected to see an increased urinary potassium excretion in claudin-2 
null mice. However, we found no change in the serum or urine K+ levels of claudin-2 null mice. 
One possibility for our finding is that the increased expression and/or activity of K+ transporters - 
such as H+-K+-ATPase (Kone and Higham 1998) - or the decreased expression and/or activity of 
K+ channels - such as  Maxi-K+ channel (Najjar, Zhou et al. 2005, Rieg, Vallon et al. 2007) - 
compensated for the impaired K+ reabsorption from the proximal tubule. This hypothesis can be 
further explored in future studies. 
         Consistent with what Muto et al. found, hypertonic saline injection led to more natriuresis in 
claudin-2 null mice. Saline loading is known to decrease proximal tubule Na+ and fluid 
reabsorption by affecting peritubular oncotic and hydrostatic pressure and hence the balance of 
Starling forces in the proximal tubule (Ichikawa and Brenner 1979). If this is mediated in part by 
claudin-2, then claudin-2 KO mice should have decreased and not increased saline-induced 
natriuresis. 
         Our interpretation of this experiment, however, differs from that of Muto et al. The finding 
that saline-induced natriuresis was greater in claudin-2 KO than WT mice suggests that 
natriuresis was not mediated by changes in paracellular Na+ transport. Brenner, Troy and 
Daugharty showed that saline-induced volume expansion reduced peritubular oncotic pressure 
thus shifting the balance of Starling forces to inhibit proximal tubule fluid reabsorption (Brenner, 
Troy et al. 1971). To the extent that proximal tubule water reabsorption is primarily transcellular 
and mediated by aquaporins, we predicted that saline expansion should inhibit primarily 
transcellular transport in the proximal tubule, which should be similar in claudin-2 KO and WT 
mice. How then to explain the observation that natriuresis is paradoxically increased in KO mice? 
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Saline loading, by decreasing proximal tubule Na+ reabsorption, increases Na+ delivery to the 
loop of Henle, where absolute and fractional Na+ reabsorption are increased. This is likely 
mediated by increased flow. In addition, because in this experiment hypertonic saline was used, 
the vasopressin release may also contribute to increased salt reabsorption by stimulating the 
activities of distal transcellular transporters such as the Na-K-Cl cotransporter (NKCC2) on the 
ascending limb of loop of Henle (TALH). Claudin-2 null mice exhibited no salt wasting phenotype 
at the baseline because the defect in proximal tubule Na+ reabsorption was compensated by the 
increased activity of distal transporters such as NKCC2. If that is the case, we postulate that, in 
claudin-2 null mice, the activity of NKCC2 was already maximally stimulated. Thus, KO mice are 
unable to further increase Na+ transport in the thick ascending limb of loop of Henle in order to 
mitigate an even greater Na+ load delivered from the proximal tubule with hypertonic saline 
expansion. Hence KO mice exhibit greater diuresis to saline than WT mice. In the future studies, 
we need to further investigate whether there is any upregulation of expression and/or activity of 





2.6 Figures and tables 
 
 
Figure 2.1 Generation of claudin-2 knockout mice: Diagram of targeting strategy. The grey bar 
indicates the single coding exon of the mouse claudin-2 gene. The targeting vector contains a 
βGeo/Puro cassette designed to replace all of the coding region and part of the 3'-UTR. The 5’ 
external probe is indicated by the green bar and the 3’ external probe by the blue bar. From 























Figure 2.2 Two breeding strategies used to generate the matched WT [+/Y] and KO [-/Y] 
littermates (red labels) used for the experiments described. Genotypes refer to alleles at the 
claudin-2 locus on the X chromosome. Fully shaded symbols are mice that are claudin-2 






Figure 2.3 Kidney weight of claudin-2 WT and KO mice. Kidney weight is represented as the ratio 






Figure 2.4 Southern blot of EcoR1-digested genomic DNA from wild-type (+/Y) and hemizygous 
(-/Y) mice indicated correct targeting. Blotting using the 5’ external probe indicated in A. should 
yield a 12.5 kb or a 3.6 kb band from the wild-type and targeted allele, respectively. Blotting with 










For Legend, see next page 
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Figure 2.5 mRNA and protein expression of claudin-2 in claudin-2 KO mice. A. Quantification of 
whole kidney mRNA levels of claudin-2 relative to β-actin in claudin-2 hemizygous KO [-/Y], 
heterozygous [+/-] and WT [+/Y] mice (n = 6 per group). B. Western blot of the whole kidney 
lysates probed with mouse anti-claudin-2 antibody showing bands at the expected size for 
claudin-2 in heterozygous [+/-] and WT [+/Y] mice. The lower panel shows an immunoblot for β-
actin as a loading control. C. Immunolocalization of claudin-2. Mouse kidney frozen sections were 
double-stained with claudin-2 antibody (Zhang, Gillihan et al. 2013)and antibody to ZO-1 (Simon, 
Lu et al. 1999) a marker of the tight junction. Note localization of claudin-2 in WT to the tight 
junctions of proximal tubules (P) but not to distal tubules (D), as well as faint basolateral staining. 
In heterozygous mice, proximal tubule staining is heterogeneous with claudin-2 absent from some 








Figure 2.6 Hypertonic saline challenge test in claudin-2 WT and KO mice. Mice were given 40 
mL/kg bw of 2% (w/v) NaCl intraperitoneally and urine collected over the subsequent 4 hours. 







Figure 2.7 Claudin mRNA expression in claudin-2 WT and KO mouse kidneys, quantitated by 







Figure 2.8 Localization and protein expression of claudin isoforms in the Cldn2[+/Y] and Cldn2[-
/Y] mice. A. Immunolocalization of claudin isoforms. Mouse kidney frozen sections were stained 
with claudin-10, claudin-7, claudin-8, and claudin-19 antibodies. B. Western blot of whole kidney 
lysates probed with rabbitanti-claudin-10, claudin-7, claudin-8 and claudin-19 antibodies showing 
bands at the expected sizes. The lower panel shows an immunoblot for villin as a loading control. 







Figure 2.9 Serum potassium (K) concentration in claudin-2 WT and KO mice. In mEq/L (n=6 mice 

















Figure 2.10 Effect of dietary potassium depletion on claudin-2 potassium handling. Urine 
potassium excretion rate, expressed as the ratio of potassium to creatinine concentration (mean 
± S.E.M., n = 6 per group), is shown in mice on a normal (0.8%) potassium diet (Day 1 to Day 5) 
followed by a potassium-deficient (0.01%) diet (Day 6 to Day 10). *p < 0.05 by paired t-test (n = 











































































Claudin19 23 15 






Husseini et al. 
2007) 
β-actin 42 15 
Sigma-Aldrich 
(#A2066) 
Rb 1:1000 O/N 
 
Villin 90 15 
Santa Cruz 
(#28283) 
Rb 1:500 O/N 
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β-Actin Forward 5'-CTA AGG CCA ACC GTG AAA AG-3' 
β-Actin Reverse 5'-ACC AGA GGC ATA CAG GGACA-3' 
Claudin 2 Forward 5'-TGGCGTCCAACTGGTGGGCT-3' 
Claudin 2 Reverse 5'-ACCGCCGTCACAATGCTGGC-3' 
Claudin 2 genotype WT Forward  5’-CAGGCTCCGAAGATACTTC-3' 
Claudin 2 genotype WT Reverse 5’-GTAGAAGTCCCGAAGGATG-3' 
Claudin 2 genotype KO Reverse 5’-CCCTAGGAATGCTCGTCAAGA-3' 
Claudin 4 Forward 5'-TGGGGACAGGCAAACCCGGA-3' 
Claudin 4 Reverse 5'-CTTGCCGGCCGTAAGGAGCC-3' 
Claudin 8 Forward 5'-TCCCTGTCAGCTGGGTTGCCA-3' 
Claudin 8 Reverse 5'-GCTCGCGCTTTAGGGCCACA-3' 
Claudin 10b Forward 5'-GAT CTG CGT TAC CGA TTC CA-3' 
Claudin 10b Reverse 5'-GCA GCG ATC ATT AGT CCT CTA C-3' 
Claudin 16 Forward 5'-GCA AGA GGG ATG TGA GGA AA-3' 
Claudin 16 Reverse 5'-CTA TGG GCC TCT GTT GCT ATT-3' 
Claudin 17 Forward 5'-GAC TCC TAC ACA TTC TGC ATCT-3' 
Claudin 17 Reverse 5'-CCA GCG ATC TGT AAG GGA TAAA-3' 
Claudin 19 Forward 5'-GAA GGA AGA GTG TGG GAG AAAC-3' 
Claudin 19 Reverse 5'-GAG CCT TCA GCC TTG AGA TTAG-3' 
 




























         Claudin-2 null mice were reported to exhibit markedly decreased renal proximal tubule Na+, 
Cl- and fluid reabsorption. Yet they have no apparent disturbance in overall Na+ balance. We 
hypothesize that the in vivo role of claudin-2 might be to maximally conserve urinary Na+ under 
conditions of extreme Na+ depletion. To test this idea, claudin-2 null mice were placed on a very 
low sodium (0.01%) diet, and Na+ excretion rate was monitored at eight-hour intervals. 
Surprisingly, claudin-2 null mice were able to maximally conserve Na+ to the same extent as their 
wild-type littermates, pointing to the existence of a very effective compensatory mechanism. 
Quantitative RT-PCR analysis showed no compensatory changes in other claudin isoforms. 
Immunoblotting for a panel of transcellular Na+ transporters showed a 23% decrease in the 
abundance of Na-H antiporter 3, only borderline increases in phosphorylated NaCl cotransporter 
and the  subunit of the epithelial Na+ channel, and no change in total or phosphorylated Na-K-
2Cl cotransporter. To test whether there was compensatory functional upregulation of 
transcellular Na+ transport activity distally, diuretic challenge tests were performed. The 
natriuresis of the mice 4 hours after intraperitoneal injection of furosemide (but not after 
hydrochlorothiazide or benzamil) was 40% higher in claudin-2 null mice than WT. 
 
3.2 Introduction 
           Muto et al. reported that claudin-2 KO renal proximal tubules exhibited much lower 
permeability to Na+ than those of WT mice (Muto, Hata et al. 2010). It was expected that claudin-
2 KO mice would exhibit salt wasting phenotypes such as increased urinary Na+ excretion, 
dehydration and hypotension. However, no salt wasting phenotype was observed at the baseline. 
One of the most likely explanations for this observation is that the impaired Na+ reabsorption is 
compensated by paracellular or transcellular transporters in distal tubules. Two kinds of 
transporters are likely to play a role in this compensation process. First, many other claudin 
isoforms are expressed along the renal tubules. Some of them, such as claudin-10 (Van Itallie, 
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Rogan et al. 2006), claudin-7 (Tatum, Zhang et al. 2010) and claudin-4 (Van Itallie, Rahner et al. 
2001) have been reported to be involved in NaCl transport in renal tubules. It is possible that other 
claudin isoforms compensated for the impaired Na+ reabsorption mediated by claudin-2. Second, 
several transcellular transporters from the renal tubule were reported to play an important role in 
the regulation of Na+ reabsorption in renal tubules. The major transcellular Na+ transporters in the 
renal tubules are: Na-H antiporter 3 (NHE3) in the proximal tubules, Na-K-2Cl cotransporter 
(NKCC2) in the thick ascending limb (Fig. 3.1A), NaCl cotransporter in the distal convoluted 
tubules (Fig. 3.1B), and epithelial Na+ channel (ENaC) in the cortical collecting duct (Fig. 3.1C). 
Also, each Na+ that is actively transported into the renal tubular cell is pumped back to the blood 
via Na-K-ATPase across the basolateral membrane (Fig. 3.1). As described in Chapter II, we 
discovered that there was no compensation from other claudin isoforms (Fig. 2.7, 2.8). Therefore 
the question is whether the transcellular transporters were upregulated, thereby compensating 
for the defect of salt reabsorption in the proximal tubule. We approached this problem in two ways. 
First, we aimed to unmask the salt wasting phenotype by challenging the mice with salt depletion. 
Our rationale was that, under extreme conditions, the compensation effect is not enough to 
obscure the salt wasting phenotype in claudin-2 null mice. As a result, we should see increased 
urinary Na+ excretion. Second, we aimed to investigate whether the expression or activity of the 
transcellular transporters was upregulated. We measured the protein expression of transcellular 
transporters in claudin-2 null mice using immunoblots with antibodies against total and 
phosphorylated NHE3, NKCC2, NCC and α, β, γ subunits of ENaC, and the Na+/K+ ATPase We 
also performed a diuretic challenge test to investigate whether there was any functional 
upregulation of these transcellular transporters. The rationale behind the diuretic challenge test 
was to determine whether the activity of these transcellular transporters was increased without 
upregulating the actual amount of the protein. By inhibiting specific transcellular Na+ transporters 
through specific diuretics, we were able to find out which transporter had higher activity in claudin-
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2 null mice by comparing the sodium excretion in the urine of WT and KO mice (Madala 
Halagappa, Tiwari et al. 2008, Tiwari, Li et al. 2009).  
 
3.3 Methods and Materials 
Immunoblotting 
        The preparation of the whole-kidney lysates has been described in previous studies (Nguyen, 
Yang et al. 2012). Briefly, one whole kidney of each mouse was diced and suspended in 2 ml of 
isolation buffer (5% sorbitol, 0.5 mM disodium EDTA, and 5 mM histidine-imidazole buffer, pH = 
7.5, with the addition of 167 mM PMSF, 9 μg/ml aprotinin, and 5 μl/ml phosphatase inh ibitor 
cocktail [Sigma]). Each sample was homogenized for 5 min at a low-speed setting with an Ultra-
Turrax T25 (IKA-Labortechnik) and then centrifuged at 2,000 g for 10 min. Supernatants were 
retained, and the pellets were rehomogenized in another 2 ml of isolation buffer, recentrifuged, 
and the resulting supernatants were pooled with the first supernatants. 
        Equal amounts of the supernatant proteins from the protein lysates were boiled at 60  ̊C for 
20 minutes and loaded to 10% acrylamide gels (Bio-Rad) for electrophoresis. After that, the 
proteins were transferred to polyvinyl di-fluoride (PVDF) membranes. Non-specific binding was 
blocked by gently agitating the membranes in 5% non-fat milk and 0.1% Tween in PBS (PBST) 
for 1 hour at room temperature. Blots were subsequently incubated in 5% bovine serum albumin 
(BSA) containing 0.1% Tween with the designated primary antibody (Table 3.2) overnight at 4°C 
with gentle agitation. After PBST washes, the blot was then incubated with the appropriate 
horseradish peroxidase-conjugated secondary antibody for 1 hour at room temperature with 
gentle agitation. After PBST washes, the blots were incubated with Pierce™ ECL Western Blotting 
Substrate (Thermoscientific). 
        Equal loading of WT and KO kidney protein lysates represented the same percentage of a 
whole kidney since there is no difference in kidney weight between WT and KO mice (Fig. 2.3). 
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The immunoblot signals were quantitated with the Odyssey Infrared Imaging System (Li-COR). 
All comparisons were performed on samples run on the same membrane. 
 
Diuretic challenge experiment 
        The protocol was modified from that described by the group of Ecelbarger (Madala 
Halagappa, Tiwari et al. 2008, Tiwari, Li et al. 2009). As shown in Figure 3.2, 10 weeks old mice 
were acclimatized for five days in metabolic cages, then administered single intraperitoneal 
injections of the following three  diuretics and their matching vehicle according to the following 
schedule: 25 mg/kg bodyweight furosemide (day 2), 1.4 mg/kg bodyweight benzamil (day 9) and 
25 mg/kg bodyweight hydrochlorothiazide (day 16). Immediately after each injection of diuretic or 
vehicle, a 4-hour collection of urine was performed. Urine Na+ concentration was measured as 
before. Furosemide (Sigma), benzamil (Sigma), hydrochlorothiazide (HCTZ, from Sigma were 
dissolved in 10% DMSO/1XPBS and had been filter sterilized before use. 
 
Low sodium diet study 
        Eight week-old mice were placed in metabolic cages for 9 days and placed on custom 
purified rodent diets (Teklad, Harlan Laboratories). A control diet containing 0.3% sodium 
(TD.120258) was provided for the first five days and then switched to a sodium-deficient diet 
containing 0.01% sodium (TD.120259) for the next four days. Urine was collected daily except on 
the first day after switching to the sodium-deficient diet, when urine was collected every eight 
hours. This was done to capture transient changes in urine Na+ excretion rate prior to attainment 
of a new steady state. 
 
Blood and urine studies 
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        Mouse whole blood was collected through cardiac puncture. The blood was left undisturbed 
at room temperature for 30 minutes to allow it to clot and the clot was removed by centrifuging at 
1,000 x g for 10 minutes in a refrigerated centrifuge. Aldosterone was measured via aldosterone 
EIA Kit – Monoclonal kit (Cayman Chemical Company). Na+ concentration was measured with a 
sodium ion-sensitive microelectrode and urine volume was measured by urine weight. 
 
Study approval 
        All animal experiments were performed in accordance with NIH guidelines on the use of 
laboratory animals and were approved by the Institutional Animal Care and Use Committees at 
the University of Kansas Medical Center. 
 
Data analysis 
        Data are expressed as means ± standard error of the means (SEM). To compare means 
between two groups we used two-way, unpaired Student’s t-tests, with p-values of <0.05 




3.4.1 Absence of salt wasting phenotype when claudin-2 null mice were treated with a low 
salt diet. 
        Age-matched adult claudin-2 WT and KO mice were placed in metabolic cages and were 
fed a control diet with normal sodium content (0.3% sodium, 0.8% potassium) for five days. Urine 
collected daily showed no significant difference in the urine Na+/creatinine concentration ratio 
between the WT and KO mice (Fig. 3.3). After the five-day acclimatization period, the mice were 
switched to a matched sodium-deficient diet (<0.01% sodium). Then urine Na+ was monitored 
every 8 hours for the first 24 hours and daily thereafter. If the KO mice had a defect in their ability 
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to maximally conserve Na+, this should have manifested as a transiently higher Na+ excretion rate 
compared to WT, which would return to a steady-state within a few days. To our surprise, we 
found no difference whatsoever (Fig. 3.3). Like WT mice, claudin-2 KO mice were able to fully 
suppress urinary Na+ excretion by more than 90%. There was also no difference in the blood 
pressure (BP), as measured by tail-cuff using volume-pressure recording, or in body weights (Fig. 
3.4). This suggests that salt wasting in the proximal tubule was completely compensated by 
increased Na+ reabsorption elsewhere in the tubule.  
 
3.4.2 Compensatory increase in Na+ reabsorption in the thick ascending limb of claudin-2 
KO mice 
        To investigate whether there was upregulation in the expression of transcellular Na+ 
transporters, we immunoblotted whole-kidney lysates for major renal tubule transcellular Na+ 
transport proteins. The protein abundance of total and activated (phosphorylated or cleaved, as 
appropriate) forms of Na+-K+-ATPase, NCC, NKCC2, and ENaC α, β and γ subunits and Na+-/K+-
ATPase was not different between WT and KO mice. Total NHE3 showed a 23% reduction, and 
phosphorylated NHE3 showed a 27% reduction in claudin-2 KO kidneys (Fig. 3.5).  But no 
difference in protein abundance was detected through immunofluorescence staining (Fig. 3.6). 
         To confirm whether there was a functional increase in the activity of NKCC2 in claudin-2 KO 
mice, and to test for increased activity of transcellular Na+ transporters in other nephron segments, 
we performed a diuretic challenge experiment. Mice were given single intraperitoneal injections 
of vehicle or diuretic on consecutive days and urine was collected for 4 hours after each injection 
to determine Na+ excretion rate. This was repeated weekly in the same set of mice with three 
different diuretics: furosemide, a NKCC2 blocker; hydrochlorothiazide (HCTZ), a NCC blocker; 
and benzamil, an ENaC blocker. WT mice responded to all three diuretics with a brisk natriuresis, 
compared to vehicle injection. KO mice had a 40% greater natriuresis in response to furosemide 
than WT mice (Fig. 3.7), indicating that increased activity of the Na-K-2Cl cotransporter, NKCC2, 
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in the thick ascending limb of Henle was the primary mechanism for compensation. The diuretic 
response to HCTZ and benzamil was also modestly increased but the difference was not 




        Our results show that claudin-2 KO mice compensate for loss of paracellular Na+ 
reabsorption in the proximal tubule by upregulating thick ascending limb transcellular transport. 
The mechanism of upregulated NKCC2 activity remains to be determined. Because there was no 
change in expression of the major paracellular and transcellular transport proteins in claudin-2 
KO mice, but there was increased natriuresis in response to furosemide, we attribute the 
compensatory increase in Na+ reabsorption to a change in the functional activity of NKCC2. 
         Studies done more than 40 years ago either by free flow micropuncture with saline 
expansion (Landwehr, Klose et al. 1967), or by tubule microperfusion at varying flow rates 
(Morgan and Berliner 1969), clearly showed that the loop of Henle increases Na+ reabsorption in 
response to the delivered load. More recently, the Cowley and Garvin labs have shown that 
increase in flow to the thick ascending limb increases generation of superoxide and secondarily 
reduces bioavailability of nitric oxide, both of which can stimulate NKCC2 activity (Ortiz and Garvin 
2002, Juncos and Garvin 2005, Abe, O'Connor et al. 2006, Cabral and Garvin 2011, Hong and 
Garvin 2012). 
         An alternative mechanism can be postulated by which high tubular flow rates could increase 
thick ascending limb Na+ reabsorption, even in the absence of any change in the surface density 
and activity of NKCC2. Burg proposed a model in which, if the capacity for Na+ reabsorption in 
the thick ascending limb is sufficiently large that it is not rate-limiting, luminal Na+ concentration 
will be lowered until it reaches a limiting concentration or "static head" (Burg 1982). In this scenario, 
increases in tubular flow rate would simply shift the point at which the static head is attained 
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distally along the thick ascending limb, so that the rate of Na+ reabsorption in the thick ascending 
limb will always be equal to the difference between the product of the flow rate and the Na+ 
concentration difference between plasma and the lumen at the static head (i.e., Na+ reabsorption 
will be proportional to the flow rate). 
       We also found a small decrease in the protein abundance of NHE3 in the claudin-2 KO kidney. 
Schnermann et al. reported that claudin-2 KO mice had an approximate 23% reduction in single-
nephron GFR, which was attributed to tubuloglomerular feedback (Schnermann, Huang et al. 
2013). It is conceivable that the reduced delivery of Na+ to the proximal tubule might signal to 
downregulate NHE3, as a mechanism to maintain glomerulotubular balance. However, our data 
(Table 4.1) and that of Muto et al. (Muto, Hata et al. 2010) show no difference in the whole kidney 
GFR between claudin-2 KO and WT, so at this point we are not able to explain this finding. 
Alternatively, the increased delivery of salt from the proximal tubule to the macula densa could 
suppress renin secretion from the juxtaglomerular apparatus, and reduce angiotensin II levels, 
thereby reducing NHE3 expression. Our analysis of the renin-angiotensin-aldosterone axis 
revealed that claudin-2 KO mice have a slight reduction in tissue renin expression in the kidney, 
but normal serum aldosterone levels (Fig. 3.9), so it is unclear whether this is the cause. 
        The finding that NKCC2 activity was increased in claudin-2 null mice also provided evidence 
as to why natriuresis was paradoxically increased in KO mice (Fig. 2.6) after a 2% NaCl challenge. 
Saline loading, by decreasing proximal tubule Na+ reabsorption, increases Na+ delivery to the 
loop of Henle, where absolute and fractional Na+ reabsorption are increased, likely mediated by 
increased flow. In addition, because in this experiment hypertonic saline was used, vasopressin 
release may also contribute by stimulating NKCC2 activity. As we have shown, our claudin-2 KO 
mice are already compensating for decreased proximal tubule Na+ reabsorption at baseline by 
increased NKCC2 activity. We postulate that this is already maximally stimulated. Thus, KO mice 
are unable to further increase thick ascending limb Na+ transport to mitigate an even greater Na+ 
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load delivered from the proximal tubule with hypertonic saline expansion. Hence KO mice exhibit 




3.6 Figures and tables 
 
Figure 3.1 Transport pathway for Na+-Cl- in the distal nephron. A. Thick ascending limb of Henle 
cells (TALH). NKCC: Na-K-2Cl cotransporter. B. Distal convoluted tubule (DCT) cells. NCC, 
thiazide-sensitive Na+-Cl- cotransporter. C. Cortical collecting duct (CCD) cells. BK: Maxi K+ 






Figure 3.2 Timeline of the diuretic challenge experiment. Yellow boxes denote 4-hour urine 
collection. Blue arrows indicate i.p. injection of the appropriate vehicle (Veh), either saline or 
methanol. Red arrows indicate i.p. injection of diuretic. Veh: Vehicle; FUR: furosemide; BNZ: 











Figure 3.3 Effect of dietary Na+ depletion on claudin-2 salt handling. Urine Na+ excretion rate, 
expressed as the ratio of Na+ to creatinine concentration (mean ± S.E.M.), is shown in mice on a 
normal (0.3%) sodium diet (Day 1 to Day 5) followed by a sodium-deficient (0.01%) diet (Day 6 to 







Figure 3.4 Body weight and blood pressure between WT and KO. A. Body weights of claudin-2 
homozygous female (Cldn2[-/-]), heterozygous female (Cldn2[+/-]), WT female (Cldn2[+/+]), KO 
male (Cldn2[-/Y]) and WT male (Cldn2[+/Y]). Results are presented as mean ± S.E.M. n=7-9 per 

















Figure 3.5 Expression of renal transcellular Na+ transport proteins. A. Immunoblots of whole 
kidney lysates with antibodies to total or phosphorylated Na-H exchanger (NHE3), thiazide-
sensitive electroneutral NaCl cotransporter (NCC), apical Na-K-2Cl cotransporter (NKCC2), 3 
subunits of the epithelial Na+ channel (ENaC-α, -β and -γ) and Na-K-ATPase α1 subunit (NKA-
α1. FL: full-length; CL: cleaved. B. Results of quantitation of the immunoblot band densities as a 









Figure 3.6 Immunofluorescence staining of Na/H exchanger-3 (NHE3) antigen in the renal 
cortex and medulla. Claudin-2 WT and KO kidneys were perfusion-fixed and cryosections 
stained for NHE3 or NKCC2. Representative pictures of cortex (A) and medulla (B) showed 
similar NHE3 expression between WT and KO, both in tubules that do not express NKCC2 (PT 
S1 and S2 in cortex, S3 and thin descending limbs in medulla), and in tubules that coexpress 
NKCC2 (cortical and medullary thick ascending limb). Images are representative of findings 





Figure 3.7. Compensatory increase in the activity of NKCC2 in claudin-2 KO mice, as determined 
by diuretic challenge. Mice were administered vehicle (Veh) I.P. on the 1st day and furosemide 
25 mg/kg bw (Fur) on the 2nd day. Urine Na+ excretion during 4 hours after Fur was greater in KO 
mice than WT. *p < 0.05 by paired t-test (n = 7-9 per group). bw: body weight; I.P: Intraperitoneal; 
Fur: furosemide. Circles represent individual measurements and horizontal lines indicate the 





Figure 3.8 Absence of compensatory increase in the activity of NCC and ENaC in claudin-2 KO 
mice, as determined by diuretic challenge. NCC and ENaC activity in WT and KO mice were 
assessed by measuring the natriuretic response over 4hr after a single i.p. bolus of 
hydrochlorothiazide (HCTZ , an NCC blocker, 25 mg/kg) or benzamil (Benz, an ENaC blocker, 
1.4 mg/kg), or matching vehicle (Veh) (n = 8 per group). Circles represent individual 





Figure 3.9 Renin and aldosterone levels in claudin-2 WT and KO mice. A. Serum aldosterone 
levels (p = NS). B. Upper panel: Western blot of the whole kidney lysates probed with a renin 
antibody, showing distinct bands for prorenin and renin. Lower panel: Immunoblot for GAPDH 
as a loading control. C. Quantitation of the blots depicted in B. Relative protein abundance 
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Chapter IV  Claudin-2 null mice exhibit less oxygen consumption efficiency, medullary 

















          We found that claudin-2 null mice were able to conserve sodium to the same extent as wild-
type mice, even during profound dietary sodium depletion, due to upregulation of the transcellular 
Na-K-2Cl transporter activity in the thick ascending limb of Henle. Given that transcellular 
transport has the capacity to fully compensate for loss of paracellular Na+ reabsorption in the 
proximal tubule, this raises the fundamental question: What then, if any, is the teleological 
purpose of paracellular transport in the proximal tubule? Paracellular transport exploits the 
potential energy from pre-existing transepithelial electrochemical gradients, set up by transcellular 
transport, to drive transport by passive diffusion without any additional ATP. We therefore 
hypothesized that the primary purpose of paracellular Na+ transport is to exploit transtubular 
electrochemical gradients to drive passive Na+ reabsorption, and hence to enhance the efficiency 
of overall renal oxygen consumption. To test this, we determined the ratio between whole kidney 
Na+ reabsorption (TNa = GFR X PNa) and oxygen consumption (QO2 = RBF X A-VO2) in 
anesthetized WT (n=8) and claudin-2 null mice (n=9). TNa/QO2 (mol/mol) in claudin-2 deficient 
mice was significantly lower than in WT. Renal O2 extraction was also higher in KO mice. These 
data show that the efficient utilization of oxygen to reabsorb Na+ in the kidney is reduced in mice 
deficient of claudin-2.  We then measured O2 content in the cortex and medulla of claudin-2 null 
mice and we found that claudin-2 null mice had medullary hypoxia that can be reversed by 
treatment with furosemide. Furthermore, when subjected to bilateral renal ischemia-reperfusion 
injury, kidneys of claudin-2 null mice exhibited more severe tubular injury, and this injury could be 
partially ameliorated by pretreatment with furosemide. Our results indicate that paracellular 
transport in the proximal tubule is required for efficient utilization of oxygen in the service of 
sodium transport. Moreover, it suggests that paracellular permeability may have evolved as a 





          Claudin-2 KO mice have impaired salt reabsorption in the proximal tubule. The salt wasted 
from the proximal tubule was compensated by increased NKCC2 activity in the thick ascending 
loop of Henle. Transmembrane transport proteins are notable for their heterogeneity (being 
encoded by ~1000 distinct genes) (Fagerberg, Jonasson et al. 2010, Uhlen, Oksvold et al. 2010) 
and substrate specificity, and regulation over a remarkable dynamic range by means of gene 
transcription, translation, protein stability, and trafficking. Given the vast capabilities and flexibility 
of transcellular transport, a fundamental and highly significant question in biology is: Why did 
epithelia evolve the capability for paracellular transport? 
            The kidney has certain features that make it a particularly good organ system in which to 
answer this fundamental question (McDonough 2012). Although the kidneys receive 25% of 
cardiac output, the oxygen tension in kidney tissue is low, ranging from 10 mm Hg in the inner 
medulla to 40 mm Hg in the cortex (Lubbers and Baumgartl 1997). Moreover, unlike all other 
organs, the kidney cannot enhance its oxygenation simply by increasing renal blood flow. 
Increasing renal blood flow does indeed increase oxygen delivery; however, it also increases 
glomerular filtration rate (GFR) and hence tubule salt transport in parallel through 
glomerulotubular balance, and so it simultaneously increases energy demand and hence oxygen 
consumption. Thus, under normal conditions the kidney medulla cannot help but live persistently 
"on the edge of hypoxia." In this rather tenuous situation, the efficiency with which oxygen is 
utilized by the kidney becomes a critical determinant of kidney oxygen tension. Renal oxygen 
consumption is determined primarily by the energy required to drive tubular sodium reabsorption 
(Brodwall 1964), which should be theoretically predictable. Transcellular transport of Na+ is 
dependent on the potential energy generated by the Na+/ K+-ATPase, which uses one molecule 
of ATP to directly drive the transport of three Na+ ions. Ninety-five percent of ATP in the kidney is 
generated by aerobic respiration (Soltoff 1986), which produces six molecules of ATP for each 
molecule of O2 consumed. Thus, the ratio of suprabasal renal oxygen consumption (QO2) to Na+ 
reabsorption (TNa) is predicted to be 1:18 (mol: mol). Alternative pathways for basolateral Na+ 
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efflux that are indirectly driven by the Na-K-ATPase, such as the electrogenic Na-bicarbonate 
cotransporter in the proximal tubules, can increase TNa modestly. However, experimentally 
measured values of QO2/TNa are in the range of 1:25 to 1:29 (Kiil, Aukland et al. 1961, Thurau 
1961, Knox, Fleming et al. 1966), indicating that the kidney uses oxygen much more efficiently 
than expected. 
        One explanation that has been proposed for this enhanced efficiency of oxygen usage is 
that the proximal tubule leverages the excess free energy in solute gradients established by active 
transcellular transport to drive additional, paracellular reabsorption of Na+, Cl-, and other solutes 
in a purely passive manner (i.e., not requiring additional energy expenditure) (Neumann and 
Rector 1976, Berry, Warnock et al. 1978). Transcellular reabsorption of Na+ in the early proximal 
tubule is coupled largely to either HCO3- or organic solutes (with a small amount of Cl- reabsorbed 
by Cl-base exchange). This, together with near-isosmotic water reabsorption, produces a luminal 
fluid that, by the time it reaches the late proximal tubule, has relatively high concentrations of Cl- 
and low HCO3-. The late proximal tubule is more permeable to Cl- than HCO3- (pCl/pHCO3 
ranging from 2 to 18 (Schafer, Patlak et al. 1975, Warnock and Burg 1977)). This permits net 
passive reabsorption of Cl-, thought to be via paracellular diffusion, and generates a lumen-
positive electrical potential (Barratt, Rector et al. 1974). This voltage difference, in turn, provides 
the driving force for passive reabsorption of Na+, again presumably via the paracellular pathway. 
It has been estimated that 32-64% of superficial proximal tubule NaCl reabsorption is passive and 
paracellular (reviewed in (Moe OW, Berry CA et al. 2000)). It is currently unknown to what extent 
paracellular transport in the proximal tubule affects renal O2 utilization in vivo, and whether this is 
physiologically important. The ability to ablate proximal tubule paracellular Na+ transport by gene 
targeting of claudin-2 in mice afforded us a unique opportunity to test this directly. 
 Absence of proximal tubule paracellular reabsorption of NaCl leads to compensatory 
transcellular Na+ transport; thus, the NaCl reabsorption by the renal tubule is less efficient. We 
hypothesize that the balance between Na+ reabsorption and oxygen consumption will be 
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disturbed in claudin-2 null mice. Dr. William Welch of Georgetown University conducted a series 
of experiments to measure the ratio of Na+ reabsorption to oxygen consumption (TNa: QO2) and 
O2 content in cortex and medulla. We predicted that oxygen consumption efficiency (TNa: QO2) in 
claudin-2 null mice is decreased compared to WT.  
          If, as we expected, there was more oxygen consumption in claudin-2 null kidney, we wanted 
to further test the hypothesis that the extra energy that was consumed attributes to increased 
NKCC2 activity. In order to test this hypothesis, we measured the oxygen content in the renal 
medulla before and after furosemide treatment in WT and claudin-2 null mice. We expected to 
find that the difference in oxygen content before and after furosemide treat was higher in claudin-
2 null mice.  
         What is the clinical implication of medullary hypoxia in claudin-2 null mice? We first 
investigated whether claudin-2 null mice suffer from chronic hypoxia by measuring the hypoxia 
marker HIF-1α and its activation. HIF-1α is a short-lived transcriptional factor that is stable in the 
nucleus (Wang and Semenza 1993). Its levels are tightly regulated by oxygen concentration via 
the ubiquitin–proteasome system (Salceda and Caro 1997). It is therefore possible that the mRNA 
levels of HIF-1α remain unchanged, and the changes in protein levels may not be detected by 
Western blot. We also used RT-PCR to measure the mRNA levels of other transcripts, such as 
vascular endothelial growth factor (VEGF), erythropoietin (EPO), glucose transporter 1 (GLUT1), 
phosphoglycerate kinase (PGK), and transferrin (TRF) that are regulated by HIF-1α. In addition, 
we measured some oxidative stress markers to test the hypothesis that oxidative stress is caused 
by renal hypoxia. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-
1α) is a key regulator of energy metabolism and is highly expressed in kidney tissue. An important 
role of PGC-1α is to stimulate mitochondrial biogenesis and thereby prevent injury from oxygen 
depletion. It was reported that PGC-1α was upregulated in tissue hypoxia (Weinberg 2011). For 
that matter, we also measured the mRNA expression of PGC-1α in the claudin-2 WT and KO 
kidneys. AMP-activated protein kinase (AMPK) is ubiquitously expressed and functions as an 
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intracellular fuel sensor by maintaining energy balance. AMPK activation requires 
phosphorylation at Thr-172 in the activation loop and is regulated by increased cellular AMP and 
decreased ATP. In other words, the ratio of pAMPK/AMPK will increase in hypoxic tissues. 
Therefore, we also performed western blots of pAMPK and AMPK in claudin-2 WT and KO mice. 
        If there is increased oxygen consumption in claudin-2 KO kidneys, we expect claudin-2 null 
mice to be more susceptible to oxygen/ATP depletion. In order to test this hypothesis, we chose 
to perform ischemia-reperfusion surgery on claudin-2 WT and KO mice to induce acute kidney 
injury. We hypothesized that claudin KO mice would show more damage than WT mice. We 
evaluated the severity of the acute kidney injury in WT and KO mice with three assays: 1) 
measurement of plasma blood urea nitrogen (BUN) and creatinine, which are indicators of renal 
function; 2) quantification of mRNA expression and protein expression of kidney injury marker 
(KIM1), which is a novel biomarker for human renal proximal tubule injury (Han, Bailly et al. 2002); 
and 3) evaluation of the degree of renal damage in kidneys stained with the Periodic Acid Schiff 
(PAS) method. The typical renal tubular damage due to ischemia includes severe tubular lysis, 
loss of brush border, and sloughed debris in tubular lumen space (Fig. 4.1). In ischemic acute 
kidney injury, the most severely injured site is the S3 segment of proximal tubules located at the 
outer stripe of the outer medulla. Dr. Timothy Fields, a very experienced and professional 
pathologist who has practiced more than 20 years in renal pathology at the University of Kansas 
Medical Center, graded the severity of the tubular injury in both WT and KO mice.  
 
4.3 Materials and Methods 
Immunoblotting 
         HIF-1α nuclear and cytosol fractions of claudin-2 WT and KO kidney lysates were prepared 
with NE-PER nuclear and cytoplasmic extraction reagents (Thermoscientific). Equal amounts of 
the supernatant proteins from the lysates were boiled at 60 ̊ C for 20 minutes, resolved by 
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electrophoresis in 10% acrylamide gels (BioRad), and then transferred to polyvinyl di-fluoride 
(PVDF) membranes. Non-specific binding was blocked by gently agitating the membranes in 5% 
non-fat milk and 0.1% Tween in PBS (PBST) for 1 hour at room temperature. Blots were 
subsequently incubated in 5% bovine serum albumin (BSA) containing 0.1% Tween with the 
designated primary antibody (Table 4.2) overnight at 4°C with gentle agitation. After PBST 
washes, the blot was then incubated with the appropriate horseradish peroxidase-conjugated 
secondary antibody for 1 hour at room temperature with gentle agitation. After PBST washes, the 
blots were incubated with Pierce™ ECL Western Blotting Substrate (Thermoscientific). 
         Equal loading of WT and KO kidney protein lysates represented the same percentage of a 
whole kidney since there is no difference in kidney weight between WT and KO mice (Fig. 2.3). 
The immunoblot signals were quantitated with the Odyssey Infrared Imaging System (Li-COR). 
All comparisons were performed on samples run on the same membrane. 
 
Urine MDA assay 
        Urinary malondialdehyde (MDA) was determined by measurement of thiobarbituric acid 
reactive substances (TBARS). Aliquots of 500 μl of urine or MDA standards were mixed with 500 
μl thiobarbituric acid (1%, pH 1.5) and boiled for 30 minutes. After cooling to room temperature, 
its absorbance was measured at 540nm with a microplate reader.  
\The final concentration of MDA was expressed as the difference between TBARS and the blank 
in order to diminish the interference of urine chromogens (Zhou, Kato et al. 2006). 
 
Immunohistochemistry staining 
         In a separate set of WT and claudin-2 KO mice, kidneys were perfusion-fixed via the heart 
with 4% paraformaldehyde in PBS. The fixed tissues were cryoprotected by overnight incubation 
with 30% sucrose in PBS, embedded in Tissue-Tek O.C.T. compound (Sakura Finetek, Torrance, 
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CA) and frozen on dry ice. Cryosections (10 μm) from WT and KO animals were s liced and 
transferred to the same Superfrost Plus-charged glass slide (Fisher) for direct side-by-side 
processing and viewing. For immunohistochemistry labeling, the sections were rehydrated and 
heated in a microwave oven in 0.01 mol/L citrate buffer, pH 6.0 for 10 minutes, and were blocked 
with 10% goat serum/PBS at room temperature for one hour. Primary antibody (Table 4.3) was 
then added to the sections and incubated overnight at 4°C with 0.2% BSA/PBS. After application 
of the primary antibody, positive staining was detected using a HRP-conjugated secondary 
antibody with DAB substrate (Vector Labs, Burlingame, CA, USA) for peroxidase staining. The 
sections were counterstained with Harris hematoxylin. 
 
RNA extraction and quantitative real-time PCR 
        RNA was extracted from tissue homogenate with TRI Reagent (Sigma-Aldrich). First-strand 
cDNA was synthesized using iScript Reverse Transcription Supermix for RT-PCR (Bio-Rad). 
Quantitative real-time PCR was performed using a CFX96 Touch™ Real-Time PCR Detection 
System and iTaq™ Universal SYBR® Green Supermix (Bio-Rad) with the primers indicated in 
Table 4.4. Expression levels were normalized to cyclophillin B levels. 
 
Renal oxygen consumption measurement 
        The ratio of net tubular Na+ transport to O2 consumption (TNa: QO2) in the kidney was 
determined using previously described techniques (Welch, Baumgartl et al. 2003, Welch, 
Mendonca et al. 2003, Welch, Blau et al. 2005). Adult mice (~12 weeks old) were anesthetized 
with isoflurane. The jugular vein, femoral artery, and renal vein were cannulated and urine 
collected by suprapubic catheter to monitor flow rate (V) and determine Na+ concentration (UNa). 
Warmed 0.154 M NaCl/1% albumin (2% body weight) was infused to replace surgical blood loss. 
To determine the glomerular filtration rate (GFR) and renal blood flow (RBF), 14C-inulin and 3H-
para-aminohippuric acid (PAH) were infused. After 30 minutes of equilibration, urine was collected 
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over two 30-minute periods, blood was sampled at the midpoint of each period for liquid 
scintillation counting, and clearances were calculated. At the end of the study, blood was drawn 
from the femoral artery and renal vein for measurement of O2 (AO2 and VO2, respectively) in a 
blood gas analyzer (i-STAT1, Abbott Labs, Abbott Park, IL, USA) and used to calculate total O2 
content. TNa is the total kidney transport of Na+, and is equal to filtered Na+ minus excreted Na+: 
TNa = [GFR X plasma Na+ concentration (PNa)] – Urine Na+ excretion (UNaV). Renal oxygen 
consumption (QO2) was calculated by the renal extraction of O2 factored by RBF, where the renal 
extraction of O2 was calculated by arterial-venous difference. Thus, QO2 = RBF X [AO2 –VO2]. 
The efficiency of O2 utilization for the transport of Na+ (not corrected for basal metabolic rate) was 
calculated by the ratio of TNa/QO2. 
 
Measurement of intrarenal oxygen tension 
        The intrarenal partial pressure of O2 (pO2) was measured with a Clark-type O2 
microelectrode (OX-10, Unisense) with tip diameter of 8-12 µm, connected to an ultra-high 
impedance picoammeter (Unisense, Aarhus, Denmark). Electrodes were inserted into the 
immobilized kidney of anesthetized mice and advanced to the outer or inner cortex (0.5 – 1.0 µm) 
or to the outer medulla (1.5 µm). The electrodes were stabilized and pO2 was recorded for two to 
four minutes. 
 
Bilateral renal ischemia-reperfusion injury model 
         Eight to ten week old mice were anesthetized with xylazine (10 mg/kg intraperitoneal) and 
ketamine (90-120 mg/kg intraperitoneal). The kidneys were exposed through flank incisions and 
both renal pedicles were occluded with microaneurysm clamps (Fine Science Tools, Foster City, 
CA). The body temperature was maintained between 36.3°C and 36.5°C using a rectal 
temperature probe and thermostatically controlled homoeothermic blanket system (Harvard 
Apparatus) set to 36.5°C. After exactly 23 minutes, the clamps were removed, reperfusion of the 
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kidneys was confirmed visually, and the mice were sutured up. They were given 0.5 ml of warm 
sterile 0.9% saline subcutaneously at the end of the operation and before they recovered from 
anesthesia. Blood was collected immediately before and at 24 hours and 48 hours after the 
surgery by tail nicking. One kidney from each mouse was harvested for RNA isolation and RT-
PCR for Kidney Injury Molecule 1 (KIM-1). The other kidney was fixed with 4% buffered 
paraformaldehyde and paraffin-embedded sections stained with Periodic Acid Schiff (PAS) for 
histological scoring. Separate groups of WT and KO mice underwent furosemide pre-treatment 
before ischemia-reperfusion surgery. In these groups, the mice were administered single 
intraperitoneal injections of 25 mg/kg bodyweight furosemide in 0.5 mL total volume of saline two 
hours prior to the start of surgery. Furosemide-treated mice were given 1 ml of saline 
subcutaneously at the end of surgery.  
         The method for quantifying acute kidney injury was adapted from that previously reported 
(Wei and Dong 2012, Zhang, Gillihan et al. 2013). Briefly, kidney images were acquired (Spot 
v5.0; Diagnostic Instruments, Sterling Heights, MI, USA) from mid-sagittal sections of whole 
kidneys stained by the PAS method. The total kidney area and areas of tubular necrosis were 
measured using ImageJ64 (Schneider, Rasband et al. 2012). The acute injury index was 
calculated by dividing the injured area by the total area. 
 
Data Analysis 
         Statistical analyses were performed with SPSS Statistics software, version 22 (IBM, NY, 
USA). Data are expressed as mean ± SEM. Student's two-tailed t-test was used to test differences 
between means in two-group comparisons. ANOVA was used to test for differences in multi-group 
experiments. Mixed factor ANOVA was used to test the between-subjects effect of genotype (WT 
vs. KO) and the within-subjects effect of diuretic (furosemide vs. vehicle) on outer medullary pO2. 
Because a significant (genotype x diuretic) interaction was detected, simple effects analysis was 
then performed to determine the effect of furosemide within each genotype and the effect of 
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genotype within vehicle- and furosemide-treated conditions. The p value was multiplied by the 
number of tests performed within each factor to protect against familywise Type I error due to 
multiple comparisons (an application of Bonferroni's procedure). Similarly, mixed ANOVA 
followed by simple effects analysis was used to test the effect of genotype on BUN within the time 
points of 0, 24 and 48 hours, as well as serum creatinine, KIM1 levels and kidney injury score at 
48 hours after bilateral renal ischemia-reperfusion injury, as well as the effect of furosemide 
pretreatment vs. control within the WT mice group and the KO mice group at each time point. P 
values <0.05 were considered significant.  
 
Study approval 
        All animal experiments were performed in accordance with NIH guidelines on the use of 
laboratory animals and were approved by the Institutional Animal Care and Use Committees at 
the University of Kansas Medical Center, Georgetown University Medical Center, and the 
University of Southern California. 
 
4.4 Results 
4.4.1 Claudin-2 null mice exhibit lower efficiency of oxygen utilization and renal medullary 
hypoxia 
         Despite the substantial defect in proximal tubule paracellular Na+ transport, it is remarkable 
that claudin-2 KO mice are able to maximally conserve Na+ even on a severely sodium-restricted 
diet. We speculated that this might be due to a compensatory increase in the activity of 
transcellular Na+ transporters further downstream along the nephron. This raises the obvious 
question of what physiological role paracellular transport plays. If transcellular transport can 
completely compensate for paracellular transport, even under the most extreme conditions, does 
this come with any cost to the organism, or is paracellular transport simply a vestigial process? 
We hypothesized that paracellular transport in the proximal tubule exists to exploit transtubular 
70 
 
electrochemical gradients to drive passive transport of NaCl and hence to maximize the efficiency 
with which this tubule segment utilizes O2 to reabsorb NaCl. Therefore, if the burden of NaCl 
reabsorption in claudin-2 KO mice is shifted distally, our hypothesis predicts that these mice will 
have increased renal O2 consumption.  
         To test this hypothesis, we determined the ratio between whole kidney Na+ reabsorption 
(TNa) and oxygen consumption (QO2) in anesthetized WT and KO mice. TNa was calculated from 
the difference between the filtered load of sodium (GFR, determined from inulin clearance, 
multiplied by PNa) and the renal Na excretion (UNaV). QO2 was determined from the renal blood 
flow (assessed by PAH clearance) factored by the arterial-venous O2 difference. GFR, RBF and 
mean arterial pressure (MAP) were not different between the groups. TNa was also similar 
between the WT and KO, whereas QO2 was 80% higher in KO mice (p <0.005)), resulting in a 
nearly 40% lower TNa/QO2 (p < 0.01) in KO mice (Table 4.1 and Fig. 4.2). 
        To investigate the effect of this increase in oxygen consumption on intrarenal oxygenation, 
we measured pO2 in the outer medulla and cortex with an O2-sensing microelectrode. In the outer 
medulla, claudin-2 KO kidneys exhibited a lower pO2 than WT kidneys (p = 0.01) (Fig. 4.3.B), 
whereas in the cortex, claudin-2 KO and WT had similar pO2 (Fig. 4.3A). Based on the results of 
our previous study that showed increased NKCC2 activity in the thick ascending limb of Henle, 
we can conclude that this increased activity comes with the price of increased oxygen 
consumption in the outer medulla. We hypothesized that furosemide treatment would block the 
extra oxygen utilization by NKCC2 in claudin-2 null mice. After treatment with furosemide, the pO2 
was not changed in the cortex of both genotypes. However, the pO2 increased in the outer medulla 
of both genotypes (Fig. 4.3B). As we expected, there was a 2.7-fold greater increase in pO2 in 
KO compared to WT mice (p <0.005 by paired t-test) (Fig. 4.3C), so that the pO2 after furosemide 
was no longer significantly different between KO and WT animals (p = 0.068). 
 
4.4.2 Absence of hypoxia markers in claudin-2 null mice 
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         To investigate whether there is any upregulation in hypoxia markers, we measured nuclear 
HIF-1α protein expression and mRNA expression of HIF-1α targeted genes. Similar to WT 
kidneys, we were unable to detect HIF-1α in the claudin-2 null kidney nucleus lysates (Fig. 4.4B). 
There was no difference in the expression of HIF-1α target genes such as EPO, VEGF, GLUT1 
and TRF between WT and KO (Fig. 4.4A). There was also no upregulation of oxidative stress 
markers, PGC-1α and ratio of pAMPK/AMPK in claudin-2 null mice (Fig. 4.5 and 4.6). 
 
4.4.3 Claudin-2 null mice are more susceptible to ischemic injury 
          Since claudin-2 null mice exhibit lower efficiency of oxygen utilization and renal medullary 
hypoxia, we hypothesized that claudin-2 null kidneys would be more susceptible to kidney injury 
from oxygen/ATP depletion. To test this hypothesis, we subjected WT and KO mice to bilateral 
renal ischemia-reperfusion injury (IRI). As shown in Figure 4.7, BUN increased in both WT and 
KO mice at 24 hours and 48 hours following reperfusion. However, the extent of elevation at both 
time points was much higher in KO compared to WT mice (p <0.005). We hypothesized that the 
increased susceptibility of KO mice to ischemic injury was due to increased activity of and hence 
oxygen consumption by NKCC2, so we tested whether pretreatment with furosemide 2 hours 
before ischemia could prevent injury. Consistent with this hypothesis, BUN elevation in KO mice 
at 24 and 48 hours after reperfusion was ameliorated by furosemide (p <0.01), whereas the 
diuretic had no effect in WT mice. The plasma creatinine concentration was also significantly 
higher in the KO compared to WT mice at 48 hours following reperfusion (1.45 mg/dl vs 0.33 
mg/dl, p <0.005), and was reduced by furosemide pretreatment in KO mice (p <0.05) but not in 
WT (Fig. 4.8A). KIM-1 is a commonly used early marker of kidney injury and correlates positively 
with the degree of renal damage in both acute and chronic injuries (Han, Bailly et al. 2002, 
Waanders, van Timmeren et al. 2010). The mRNA level of KIM-1 showed identical trends to that 
of BUN and creatinine (Fig. 4.8B), and KIM-1 protein expression by immunohistochemistry 
showed consistent findings (Fig. 4.9).  
72 
 
        Morphological studies at 48 hours showed evidence of tubular injury (e.g., tubular necrosis, 
sloughed cells, mitotic figures, and luminal casts) that were most readily identified within the S3 
segment of the proximal tubule. In WT mice, only a portion of the renal tubules (~50%) in the 
outer medulla showed morphological features of ischemic injury such as loss of the brush border, 
flattening of the epithelium, tubular necrosis, and luminal casts, while the renal cortex was almost 
completely intact. However, in KO mice, almost all the renal tubules (~95%) in the outer medulla 
exhibited ischemic injury, and tubule injury, especially within proximal tubules, was also observed 
in parts of the renal cortex (Fig. 4.10). We graded the severity of the renal tubular injury by 
estimating the proportion of the entire kidney area that was involved. The KO kidneys had a larger 
area of injury compared to WT (p <0.005). Finally, pretreatment with furosemide had no significant 
effect on the severity of injury in WT mice, but significantly ameliorated the injury in KO mice (p = 
0.018, Fig. 4.10 and Fig. 4.11). These findings suggest that claudin-2 null mice are more 
susceptible to acute ischemic renal injury because of upregulated NKCC2 activity in the thick 
ascending limb and hence increased outer medullary oxygen consumption. 
 
4.5. Discussion 
         The shift in burden of Na+ reabsorption from the proximal tubule to the thick ascending loop 
of Henle in claudin-2 KO mice occurs at the expense of increased oxygen consumption. Viewed 
thermodynamically, the free energy cost of transporting Na+ uphill is dependent on the 
transtubular concentration gradient (specifically, it is proportional to the negative logarithm of the 
concentration gradient (Stephenson, Tewarson et al. 1974)). Because of the large water 
permeability of the proximal tubule, there is almost no detectable transtubular concentration 
gradient for Na+ in this nephron segment (Windhager and Giebisch 1961, Barratt, Rector et al. 
1974)), whereas the tubular fluid/plasma Na+ concentration ratio approaches 0.2 to 0.4 when 
measured by micropuncture at the end of the thick ascending loop of Henle (Burg and Good 1983). 
Thus, Na+ reabsorption in the thick ascending loop of Henle necessarily requires more energy 
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and hence greater O2 consumption than the same amount of reabsorption occurring in the 
proximal tubule. 
         The consequence of the increased O2 consumption was that the outer medullas of claudin-
2 KO mice were more hypoxic than those of WT mice even at baseline. We expected upregulation 
of chronic hypoxia markers in claudin-2 KO kidneys. However, there was no change in hypoxia-
inducible factor-1, indicated by lack of increased HIF-1 protein translocation to the nucleus, and 
no difference in RNA expression of HIF-1 target genes such as VEGF, EPO, GLUT-1 and PGK 
between WT and KO. There was also no change in reactive oxygen species, PGC-1α and the 
ratio of pAMPK/AMPK. Our explanation is that the medullary hypoxia in claudin-2 null mice is 
relatively mild compared to the hypoxic conditions reported in the previous studies describing 
upregulation of HIF-1α (Semenza 2000). The small reduction of pO2 that is observed in our 
claudin-2 null mice is not big enough to induce HIF1α activation. Nevertheless, this mild hypoxia 
reflects a serious deficit in the ability of the kidney to reduce O2 consumption to match delivery. 
This is demonstrated by our finding that a modest reduction in O2 delivery, imposed by brief (23 
minutes) renal artery clamping, was sufficient to dramatically tip the delicate balance between O2 
delivery and consumption, and greatly increased the susceptibility of the KO mice to ischemic 
tubule injury. When furosemide was given to claudin-2 KO mice, there was a 2.7-fold greater 
increase in pO2 in the outer medulla compared to WT mice. Furosemide pretreatment before 
ischemic reperfusion injury partially alleviated the injury, presumably by inhibiting NKCC2 and 
hence increasing pO2 in the outer medulla. It is conceivable that inherited or acquired variations 
in the proximal tubule paracellular transport pathway in humans might similarly affect the clinical 
susceptibility to acute ischemic kidney injury. HIF-1α was reported to be protective in ischemic 
reperfusion surgery (Jamadarkhana, Chaudhary et al. 2012). Ischemic preconditioning can be a 
protective factor for the subsequent acute ischemic injury due to pre-upregulated HIF1α activation 
and the subsequent enhancement of renoprotective gene expression (Goldfarb, Rosenberger et 
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al. 2006). However, the absence of upregulation of HIF-1α suggests that the severity of the acute 
kidney injury is not influenced by HIF-1α. 
        The findings described here may provide insights into the evolutionary purpose of tight 
junctions. Transport of solutes and water by epithelia plays a critical role in the homeostasis of 
body fluid compartments in higher organisms and consumes a substantial amount of energy. Why 
epithelia evolved to have a leaky paracellular pathway is unknown. One possibility is that 
paracellular transport simply adds to the capacity of transcellular transport. However, this seems 
to add unnecessary complexity since transcellular transport proteins are so abundant and 
versatile already. Here we found that the defect in paracellular sodium reabsorption in the 
proximal tubule of the kidney in claudin-2 null mice can be completely compensated under even 
the most extreme circumstances that could be encountered in vivo (near-zero sodium diet), 
confirming that the contribution of paracellular transport is dispensable. The results that we report 
here suggest a more nuanced reason for the existence of a paracellular transport pathway, 
namely that it evolved to enhance the efficiency of energy and oxygen utilization by the renal 
tubule epithelium. We show that the cost of losing paracellular transport is increased oxygen 





4.6 Figures and tables 
 
 
Figure. 4.1 Renal histology after ischemic acute kidney injury. Top: kidney tissues from C57BL/6 
mice with 30 min of bilateral renal ischemia and 48 h of reperfusion or sham operation were 
stained by hematoxylin and eosin. IM, inner medulla. CT, cortex. Bottom: enlarged images of 
boxed area in the upper panels (Wei and Dong 2012).  
 
 





Figure 4.2 Role of claudin-2 in renal O2 utilization. A. Relationship between TNa and QO2 in 
individual claudin-2 WT and KO mice, expressed per gram of kidney weight (g kwt). B. The 
efficiency of oxygen utilization for renal Na+ transport, TNa/QO2, calculated from the data in A (n=7 














Figure 4.3 Effect of claudin-2 KO on intrarenal pO2, as measured with O2-sensing microelectrodes. 
A, B. pO2 in kidney cortex (A) and outer medulla (B) at baseline (Ctrl) and after treatment with 
furosemide (Fur). *p = 0.01, **p < 0.001; NS, non-significant by ANOVA. C. Change in pO2 (ΔpO2) 












Figure 4.4 Absence of HIF-1α activation in claudin-2 KO kidney. A. Quantification of whole kidney 
mRNA levels of HIF-1α target genes in claudin-2 WT and KO mice, relative to β-actin. TRF: 
transferrin; GLUT-1: Glucose transporter 1; PGK: Phosphoglycerate kinase; EPO: erythropoietin; 
VEGF: vascular endothelial growth factor. The fold change is presented as mean ± S.E.M. B. 
Western blots of kidney nuclear tissue lysate from WT and KO mice. Upper panel is probed with 
rabbit-anti-HIF-1α antibody. The last lane contains human renal cell carcinoma lysate (RCC) as 
a HIF-1α expression control. HIF-1α is absent in both WT and KO kidney at baseline. Lower panel 







Figure 4.5 Absence of upregulation of oxidative stress markers in claudin-2 KO kidneys compared 
to WT kidneys at baseline. A. Urinary malondialdehyde (MDA) excretion is expressed as the ratio 
of urinary MDA concentration to creatinine concentration (mean ± S.E.M.). B. mRNA expression 
of oxidative stress response genes. Quantification of whole kidney mRNA levels of OH-1 and Nrf2 
gene relative to β-actin. OH-1: heme oxygenase 1; Nrf2: nuclear factor, erythroid derived 2. The 







Figure 4.6 Absence of upregulation of mitochondria biogenesis in claudin-2 KO kidneys compared 
to WT kidneys at baseline. A. Western blots of whole kidney tissue lysate from WT and KO mice. 
Upper panel was probed with rabbit-anti-pAMPK antibody, lower panel was probed with rabbit-
anti-AMPK. B. mRNA expression of peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (PGC-1α). Quantification of whole kidney mRNA levels of PGC-1α gene 








Figure 4.7 Effect of claudin-2 KO on susceptibility to acute renal ischemia: measurement of 
plasma BUN levels. BUN levels at 0, 24 and 48 hours following bilateral renal IRI in claudin-2 
KO and WT littermates, with or without (control) furosemide pretreatment. p < 0.005 for KO 
control vs. WT control, and for KO control vs. KO furosemide; NS, p not significant for WT 





Figure 4.8 Effect of claudin-2 KO on susceptibility to acute renal ischemia: measurement of 
plasma creatinine and KIM1 mRNA. A. Plasma creatinine levels at 48 hours after IRI.  B. KIM-1 
mRNA levels in kidneys at 48 hr after IRI (normalized to cyclophilin B). CyPB: cyclophilin B; IRI: 







Figure 4.9 Confirmation of kidney injury by KIM-1 protein staining. Representative images are 
shown of rabbit anti-KIM-1 antibody immunohistochemistry staining of the kidney cortex (A,C) and 






Figure 4.10 Histological analysis of acute kidney injury. Representative images are shown of 
periodic acid-Schiff (PAS) stained WT (A-C) and KO (D-F) kidneys 48 hrs following IRI. A and D 
are low power views (100 µm scale bar). B, E are high power views of the cortex, while C, F are 
high power views of the outer medulla (50 µm scale bar). G. Histological scoring of acute injury, 
expressed as % of kidney area involved. *p < 0.001 by t-test, n = 6-8 per group. Magnification: A 





Figure 4.11 Histological analysis of acute kidney injury in mice pretreated with furosemide. 
Representative images are shown of periodic acid-Schiff (PAS)-staining WT (A, B) and KO (C, D) 
kidneys 48 hours following IRI. A, C are low power overviews of the whole kidney section. B, D 
are higher power views showing the cortex and outer medulla (100µm scale bar). Please see 








 WT (n = 8) KO (n = 9) p value 
GFR (µl/min/g kw) 846 ± 40 911 ± 38 0.26 
RBF (ml/min/g kw) 7.69 ± 0.35 7.72 ± 0.24 0.96 
MAP (mm Hg) 101.8 ± 3.3 105.1 ± 2.6 0.45 
TNa (µmol/min/g kw) 126.9 ± 6.0 138.2 ± 6.3 0.22 
QO2 (µmol/min/g kw) 8.06 ± 0.74 14.50 ± 1.55 0.003 
TNa/QO2 (mol/mol kw) 16.36 ± 1.31 10.34 ± 1.33 0.007 
 
Table 4.1 Renal hemodynamics and function in anesthetized mice. GFR, glomerular filtration rate; 
RBF, renal blood flow; MAP, mean arterial pressure; TNa, net renal Na reabsorption; QO2, renal 























HIF-1α 150 30 Novus (#NB100-449) Rb 1:1000 O/N 
Lamin 
A/C 
70-28 30 Cell Signaling (#2032) Rb 1:1000 O/N 
 


















Kim-1 Novus (#NBP1-76701) Rb 1:500 O/N 
 





Kim-1 Forward 5'-CAG GAA GAC CCACGACTA TTTC-3' 
Kim-1 Reverse 5'-GTG TGT AGA TGT TGG AGG AGTG-3' 
Cyclophilin B Forward 5'-CGA GTC GTC TTT GGA CTC TTT-3' 
Cyclophilin B Reverse 5'-GCC AAA TCC TTT CTC TCC TGT A-3' 
OH-1 Forward 5'-CTC CCT GTG TTT CCT TTC TCT C-3’ 
OH-1 Reverse 5’-GCT GCT GGT TTC AAA GTT CAG-3’ 
Nrf2 Forward 5’-CTC CGT GGA GTC TTC CAT TTA C-3’ 
Nrf2 Reverse 5’-GCA CTA TCT AGC TCC TCC ATT TC-3’ 
VEGF-A Forward 5’-CCA CGT CAG AGA GCA ACA TCA-3’ 
VEGF-A Reverse 5’-TCA TTC TCT CTA TGT GCT GGC TTT-3’ 
GLUT-1 Forward 5’-ATG GAT CCC AGC AGC AAG-3’ 
GLUT-1 Reverse 5’-CCA GTG TTA TAG CCG AAC TGC-3’ 
PGK Forward 5’-GGA AGC GGG TCG TGA TGA-3’ 
PGK Reverse 5’-GCC TTG ATC CTT TGG TTG TTT G-3’ 
TRF Forward 5’-TGG AGA CAG ATG CTC CCT CC-3’ 
TRF Reverse 5’-TTT GTG CTC TGT GTA TGT GGT AAG G-3’ 
EPO Forward 5’-CAT CTG CGA CAG TCG AGT TCT G-3’ 
EPO Reverse 5’-CAC AAC CCA TCG TGA CAT TTT C-3’ 
 

































        The in vitro characterization of claudin-2 functions indicates that claudin-2 forms a cation 
selective pore (Furuse, Furuse et al. 2001, Amasheh and Meiri et al. 2002). Na+ transport in renal 
proximal tubules has been well characterized as well; approximately 60% of glomerulus-filtered 
Na+, K+, and Cl- ions are reabsorbed in renal proximal tubules, 40% of which are transported 
through the paracellular pathway. Claudins are a family of tight-junction transmembrane proteins 
that regulate paracellular ion permeability. Cation-selective claudin-2 is mainly expressed in renal 
proximal tubules. 
        Due to the abundance of transporters involved in transcellular transport of Na+ and other 
claudin isoforms in renal tubules, the salt wasting phenotypes of claudin knockout mice are 
usually quite mild (Muto, Hata et al. 2010, Tatum, Zhang et al. 2010). These studies might lead 
to the misunderstanding that paracellular transport is not important in epithelial transport. 
However, the fact that renal epithelia have evolved to contain a leaky paracellular pathway has 
led us to speculate on the evolutionary purpose and significance of tight junctions.    
        Our work sought to explore the physiological significance of paracellular transport in two 
ways. First, it explored how the kidney’s transcellular Na+ transport compensated for the loss of 
claudin-2.  Second, we assessed oxygen-utilization efficiency and susceptibility to acute ischemic 
injury in claudin-2 null mice. We demonstrated that, when the paracellular transport pathway is 
disrupted in the renal proximal tubule, transcellular transport in the thick ascending limb of the 
loop of Henle can compensate for its loss. The price for increased transcellular transport is 
increased oxygen consumption, thereby rendering the tissue more susceptible to ischemic injury. 
 
5.2 Summary of chapter II and chapter III 
In the first part of our work, we performed a general characterization of the claudin-2 null 
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mice that we purchased from Mutant Mouse Regional Resource Centers. We were able to show 
that the claudin-2 gene was successfully disrupted in the mouse genome. Then, we performed 
RT-PCR and confirmed the absence of any expression of claudin-2 mRNA and protein. We 
performed immunofluorescence and confirmed lyonization in heterozygous mice (Cldn2 [+/-]). We 
performed a 2% saline challenge test in order to confirm the salt wasting phenotype in claudin-2 
null mice during a high salt challenge. A thorough characterization of our claudin-2 null mice model 
provided a solid foundation for subsequent experiments. 
         We found that the compensation of Na+ reabsorption was so efficient that claudin-2 null 
mice exhibited no excessive urine Na+ loss even when challenged with a sodium-deficient diet. 
This result surprised us, and we sought to investigate how this compensation occurred.  We 
approached this investigation by measuring changes in both claudin isoforms and transcellular 
Na+ transporters. We found no significant difference in claudin isoform expression or localization 
between WT and claudin-2 KO mice. Following this, we quantitated the protein expression of a 
majority of the transcellular transporters and found no increase in the amount of protein in the 
transcellular transporters, NKCC2, NHE3, NCC, or ENaC. These results led us to consider that 
changes in transcellular transporter activity may occur without changes in protein abundance and 
its phosphorylation status (Madala Halagappa, Tiwari et al. 2008, Tiwari, Li et al. 2009). In order 
to test this hypothesis, we performed a diuretic challenge test. When claudin-2 null mice were 
subjected to a furosemide challenge test, we observed a 40% increase in natriuresis in the 
knockout compared to WT mice. These results indicated that the loss of paracellular transport in 
claudin-2 null mice was compensated by an increase in NKCC2 activity in the thick ascending 
limb of loop of Henle. Although NKCC2 was not upregulated in terms of its protein expression or 
phosphorylation status, it is known that distal Na+ delivery to the thick ascending limb can lead to 
increased NKCC2 activity without changing these parameters. Distal Na+ delivery increases 
NKCC2 activity in at least two ways. First, increased Na+ concentration in the lumen can directly 
stimulate Na+ transport by NKCC2 in the thick ascending limb (Morgan and Berliner 1969). 
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Second, increased Na+ delivery increases NKCC2 activity by reducing nitric oxide, which is an 
inhibitor of NKCC2.  Na+ delivery inhibits nitric oxide bioavailability by increasing generation of 
superoxide (Abe, O'Connor et al. 2006) and nitric oxide inhibits NKCC2 activity by increasing 
cGMP (Plato, Stoos et al. 1999). An alternative explanation is that NKCC2 activity can be 
upregulated in response to increased tubular flow rate in thick ascending limb (Burg and Good 
1983). Burg proposed that if the capacity for Na+ reabsorption in the thick ascending limb is 
sufficiently large that it is not rate-limiting, luminal Na+ concentration will be lowered until it reaches 
a limiting concentration or "static head". In claudin-2 KO mice, increased tubular flow rate would 
simply shift the point at which the static head is attained distally along the thick ascending limb, 
so that the Na+ reabsorption will be proportional to the flow rate. 
 
5.3 Summary of chapter IV 
          The work outlined in chapter III established that claudin-2 null mice were able to conserve 
sodium to the same extent as wild-type mice, even during periods of profound dietary sodium 
depletion. Subsequent work determined this to be due to the upregulation of transcellular Na-K-
2Cl cotransporter activity in the thick ascending limb of Henle. We hypothesized that the primary 
purpose of paracellular Na+ transport is to exploit transtubular electrochemical gradients in order 
to drive passive Na+ reabsorption and enhance the efficiency of overall renal oxygen 
consumption. To test this hypothesis, we determined the ratio between whole-kidney Na+ 
reabsorption and oxygen consumption in both WT and claudin-2 null mice. As expected, TNa/QO2 
in claudin-2 deficient mice was significantly lower than in WT.  We then measured the tissue pO2 
within cortex and medulla of claudin-2-null mice and found that claudin-2-null mice have relative 
medullary hypoxia.  When we treated both WT and claudin-2-null mice with furosemide, the pO2 
increased in the outer medulla of both genotypes. However, as expected, there was a much 
greater increase in pO2 in KO as compared to WT mice.  
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       When subjected to bilateral renal ischemia-reperfusion injury, the kidneys of claudin-2-null 
mice exhibited more severe tubular injury than WT mice. This was shown by higher BUN and 
creatinine, higher expression of Kidney Injury Molecule-1 and higher histological scoring of injury 
in claudin-2 null mice. Furosemide pretreatment before ischemic reperfusion injury partially 
alleviated the injury, presumably by inhibiting NKCC2 and hence increasing pO2 in outer medulla. 
It is conceivable that inherited or acquired variations in the proximal tubular paracellular transport 
pathway in humans might similarly affect the clinical susceptibility to acute ischemic kidney injury. 
 
5.4 Limitations 
        Several limitations of this dissertation work deserve mention. Because the claudin-2 gene is 
on the X chromosome, we chose to confine our analysis to male WT and KO mice to simplify the 
breeding scheme. Also, the claudin-2 coding sequence has been globally deleted in our claudin-
2 null mice. Since claudin-2 is expressed in other transporting epithelia and especially in the 
intestine, it is theoretically possible that absence of claudin-2 in other tissues could explain some 
of our findings. This is very unlikely, though, because the key experiments, such as assays of 
oxygen consumption, are specifically confined to the kidney. Moreover, whereas claudin-2 is 
expressed throughout the intestinal epithelium including the villi in infant mice, it is confined to the 
crypts in adults (Tamura, Hayashi et al. 2011). Consistent with this, in adult claudin-2 null mice 
there was little change in the cation permeability of the intestine (25% decrease in PNa compared 
to WT mice (Tamura, Hayashi et al. 2011)). We therefore believe that in adults claudin-2 likely 
plays a minor role in intestinal Na+ absorption. Our interpretation of the results here is also based 
on the assumption that the renal phenotype of the KO mice is due to loss of proximal tubular 
claudin-2. However, our lab (Enck, Berger et al. 2001) and others (Kiuchi-Saishin, Gotoh et al. 
2002, Lee, Chou et al. 2015) have shown that claudin-2 is also highly expressed in the upper 
portion of the thin descending limb of long-looped nephrons. The role of this nephron segment is 




5.4 Future Directions 
        This dissertation work was able to use claudin-2 null mice to prove that, when paracellular 
transport is dysfunctional within the proximal tubule of the kidney, transcellular transport will 
compensate for its loss. This compensation increases energy consumption and susceptibility to 
ischemic insult. In the future, there are many ways to investigate the wider significance of 
paracellular transport in the energy efficiency of epithelial transport. There are still questions 
remaining to be answered. In Chapter III, we found increased NKCC2 activity in the thick 
ascending limb of claudin-2 null mice. However, we still don’t have clear evidence to show how 
the NKCC2 activity is regulated. We speculate that the increased luminal Na+ concentration 
directly stimulates NKCC2 activity. In order to prove this, it would be interesting if we could 
measure the luminal Na+ concentration in the thick ascending limb in both WT and claudin-2 KO 
kidneys in order to determine if there is an increased Na+ concentration in claudin-2 KO mice. 
Also, as Figure 3.8 shows, there is no significant difference in urine Na+ excretion between WT 
and claudin-2 KO mice after HCTZ and benzamil treatment. However, we did notice a trend that 
claudin-2 null mice had more natriuresis after blocking NCC and ENaC with these diuretics. We 
speculate that it is possible that there is an increase in the activity of NCC and ENaC that our 
diuretic challenge test was not able to readily demonstrate. Further, it would be interesting to 
determine the exact percentage of each transporter’s contribution to the compensatory salt 
reabsorption in claudin-2 null mice. 
         We speculate that our findings in claudin-2 null mice can be also applied to the investigation 
of other claudin isoforms in the kidney and the other organs.  First, we can test a similar hypothesis 
by investigating the physiological significance of other claudins in the renal tubule. For example, 
claudin-7 and claudin-10a are both implicated in paracellular NaCl transport in the distal tubule 
and the proximal tubule, respectively. It would be interesting to perform our oxygen consumption 
assay and ischemic reperfusion surgery on claudin-7 and claudin-10a KO mice to test the 
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hypothesis that they also have increased oxygen consumption and susceptibility to ischemic 
injury.  
         Second, we can investigate the physiological significance of claudins in other organs. For 
example, in small intestine, the cation pores, claudin-2 and claudin-15, are believed to mediate 
the back-leak of Na+ into the intestinal lumen and facilitate Na+ dependent glucose and amino 
acid reabsorption (Wada, Tamura et al. 2013). When claudin-2 and claudin-15 are simultaneously 
knocked out, mice are not able to reabsorb glucose and amino acids. In this case, transcellular 
transporter activity may be upregulated in an attempt to absorb these nutrients. It would be 
interesting to perform an oxygen consumption assay on the claudin-2/claudin-15 double KO small 
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